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A B S T R A C T
Background
Operations on structures in the chest (usually the lungs) involve cutting between the ribs (thoracotomy). Severe post-thoracotomy
pain can result from pleural (lung lining) and muscular damage, costovertebral joint (ribcage) disruption and intercostal nerve (nerves
that run along the ribs) damage during surgery. Poor pain relief after surgery can impede recovery and increase the risks of developing
complications such as lung collapse, chest infections and blood clots due to ineffective breathing and clearing of secretions. Effective
management of acute pain following thoracotomy may prevent these complications and reduce the likelihood of developing chronic
pain. A multi-modal approach to analgesia is widely employed by thoracic anaesthetists using a combination of regional anaesthetic
blockade and systemic analgesia, with both non-opioid and opioid medications and local anaesthesia blockade.
There is some evidence that blocking the nerves as they emerge from the spinal column (paravertebral block, PVB) may be associated
with a lower risk of major complications in thoracic surgery but themajority of thoracic anaesthetists still prefer to use a thoracic epidural
blockade (TEB) as analgesia for their patients undergoing thoracotomy. In order to bring about a change in practice, anaesthetists need
a review that evaluates the risk of all major complications associated with thoracic epidural and paravertebral block in thoracotomy.
Objectives
To compare the two regional techniques of TEB and PVB in adults undergoing elective thoracotomy with respect to:
1. analgesic efficacy;
2. the incidence of major complications (including mortality);
3. the incidence of minor complications;
4. length of hospital stay;
5. cost effectiveness.
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Search methods
We searched for studies in the Cochrane Central Register of Controlled Trials (CENTRAL 2013, Issue 9); MEDLINE via Ovid (1966
to 16 October 2013); EMBASE via Ovid (1980 to 16 October 2013); CINAHL via EBSCO host (1982 to 16 October 2013); and
reference lists of retrieved studies. We handsearched the Journal of Cardiothoracic Surgery and Journal of Cardiothoracic and Vascular
Anesthesia (16 October 2013). We reran the search on 31st January 2015. We found one additional study which is awaiting classification
and will be addressed when we update the review.
Selection criteria
We included all randomized controlled trials (RCTs) comparing PVB with TEB in thoracotomy, including upper gastrointestinal
surgery.
Data collection and analysis
We used standard methodological procedures expected by Cochrane. Two review authors (JY and SG) independently assessed the
studies for inclusion and then extracted data as eligible for inclusion in qualitative and quantitative synthesis (meta-analysis).
Main results
We included 14 studies with a total of 698 participants undergoing thoracotomy. There are two studies awaiting classification. The
studies demonstrated high heterogeneity in insertion and use of both regional techniques, reflecting real-world differences in the
anaesthesia techniques. Overall, the included studies have a moderate to high potential for bias, lacking details of randomization, group
allocation concealment or arrangements to blind participants or outcome assessors. There was low to very low-quality evidence that
showed no significant difference in 30-day mortality (2 studies, 125 participants. risk ratio (RR) 1.28, 95% confidence interval (CI)
0.39 to 4.23, P value = 0.68) and major complications (cardiovascular: 2 studies, 114 participants. Hypotension RR 0.30, 95% CI
0.01 to 6.62, P value = 0.45; arrhythmias RR 0.36, 95% CI 0.04 to 3.29, P value = 0.36, myocardial infarction RR 3.19, 95% CI 0.13,
76.42, P value = 0.47); respiratory: 5 studies, 280 participants. RR 0.62, 95% CI 0.26 to 1.52, P value = 0.30). There was moderate-
quality evidence that showed comparable analgesic efficacy across all time points both at rest and after coughing or physiotherapy (14
studies, 698 participants). There was moderate-quality evidence that showed PVB had a better minor complication profile than TEB
including hypotension (8 studies, 445 participants. RR 0.16, 95% CI 0.07 to 0.38, P value < 0.0001), nausea and vomiting (6 studies,
345 participants. RR 0.48, 95% CI 0.30 to 0.75, P value = 0.001), pruritis (5 studies, 249 participants. RR 0.29, 95% CI 0.14 to
0.59, P value = 0.0005) and urinary retention (5 studies, 258 participants. RR 0.22, 95% CI 0.11 to 0.46, P value < 0.0001). There
was insufficient data in chronic pain (six or 12 months). There was no difference found in and length of hospital stay (3 studies, 124
participants). We found no studies that reported costs.
Authors’ conclusions
Paravertebral blockade reduced the risks of developing minor complications compared to thoracic epidural blockade. Paravertebral
blockade was as effective as thoracic epidural blockade in controlling acute pain. There was a lack of evidence in other outcomes. There
was no difference in 30-day mortality, major complications, or length of hospital stay. There was insufficient data on chronic pain
and costs. Results from this review should be interpreted with caution due to the heterogeneity of the included studies and the lack of
reliable evidence. Future studies in this area need well-conducted, adequately-powered RCTs that focus not only on acute pain but also
on major complications, chronic pain, length of stay and costs.
P L A I N L A N G U A G E S U M M A R Y
Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Review question
We reviewed the evidence about the effect of paravertebral block and thoracic epidural for patients undergoing thoracotomy. We found
14 studies.
Background
Operations on structures in the chest (usually the lungs) involve cutting between the ribs (thoracotomy) resulting in severe pain. Poor
pain relief post-surgery can slow down recovery and increase risks of developing complications. Effective management of acute pain
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following thoracotomy may prevent these complications and reduce the likelihood of developing long-term pain.We wanted to discover
whether blocking the nerves as they emerge from the spinal column (paravertebral block, (PVB)) was better or worse than using central
neuraxial nerve block (thoracic epidural block, (TEB)).
This evidence is current to 16th October 2013. We reran the search on 31st January 2015. We found one additional study which is
awaiting classification and which we will include when we update the review.
Study characteristics
We found 14 studies involving 698 participants. Whilst all 14 studies compared broadly the analgesic efficacy of PVB and TEB in
participants undergoing open thoracotomy, there were significant differences in the timing, method of insertion and medications used
in PVB and TEB. This makes direct comparison difficult. Patient follow-up was limited to the immediate post-surgery period (up
to five days post-surgery) with only two studies reporting long-term outcomes such as chronic pain. There are two studies awaiting
classification.
Key results
We found no difference between PVB and TEB in terms of death at 30 days and major complications. PVB appeared to be as effective
as TEB in pain control post-surgery. PVB was associated with minor complications such as low blood pressure, nausea and vomiting,
itching and urinary retention when compared to TEB. We did not find any difference in length of hospital stay between PVB and
TEB. There was insufficient information to assess chronic pain and health costs.
Quality of evidence
We found low-quality evidence for death at 30 days, with limited information provided by only two studies reporting this outcome. We
only found low to very low-quality evidence for major complications due to lack of information, with only one study reporting these
outcomes. We found moderate-quality evidence for acute pain control in the immediate postoperative period. We found moderate-
quality evidence for minor complications.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Paravertebral blockade compared to thoracic epidural blockade for patients undergoing thoracotomy (30-day mortality and major complications)
Patient or population: Patients undergoing thoracotomy
Setting: In hospitals, worldwide
Intervention: Paravertebral blockade
Comparison: Thoracic epidural blockade
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with PVB Risk with TEB
30-day mortality Study population RR 1.28
(0.39 to 4.24)
125
(2 RCTs) LOW 1
Only 2 studies reported
number of participants
that died within 30 days63 per 1000 80 per 1000
(24 to 265)
Low
64 per 1000 82 per 1000
(25 to 271)
Cardiovascular complica-
tions
Study population Hypotension requiring in-
otropes RR 0.30
(0.01 to 6.62)
Arrhythmias
RR 0.36 (0.04, 3.29)
Myocardial Infarction
RR 3.19 (0.13, 76.42)
114
(2 RCTs) LOW 1
Only 2 studies reported
number of participants
withmajor cardiovascular
complications
37 per 1000 22 per 1000
(4 to 105)
Moderate
111 per 1000 64 per 1000
(13 to 311)
Respiratory complica-
tions
Study population RR 0.62
(0.26 to 1.52)
280
(5 RCTs) LOW 3
All respiratory outcomes
combined
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134 per 1000 83 per 1000
(35 to 204)
Moderate
163 per 1000 101 per 1000
(42 to 248)
Neurological complica-
tion (Delirium)
Study population RR 0.30
(0.09 to 0.99)
125
(2 RCTs) MODERATE 13
Definition of delirium un-
clear
156 per 1000 47 per 1000
(14 to 155)
Moderate
264 per 1000 79 per 1000
(24 to 261)
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidence
High quality: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
1Only two studies reported outcome. Downgraded for small number of events, insufficient data available and for imprecision.
2Only one study reported outcome. Downgraded for small numbers of events, insufficient data available and for imprecision.
3Downgraded for lack of definition of delirium
5
P
a
ra
v
e
rte
b
ra
l
b
lo
c
k
v
e
rsu
s
th
o
ra
c
ic
e
p
id
u
ra
l
fo
r
p
a
tie
n
ts
u
n
d
e
rg
o
in
g
th
o
ra
c
o
to
m
y
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
6
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
B A C K G R O U N D
Description of the condition
Operations on structures in the chest (usually the lungs) involve
cutting between the ribs (thoracotomy). Post-thoracotomy pain
results from pleural (lung lining) and muscular damage, costover-
tebral joint (ribcage) disruption and intercostal nerve (nerves that
run along the ribs) damage during surgery (Ng 2007). It is one of
the most severe types of postoperative pain. Poor pain relief can
lead to immobility and ineffective breathing and clearing of secre-
tions, resulting in susceptibility to lung collapse (atelectasis), chest
infections (pneumonia) and blood clots (pulmonary embolism)
(Richardson 1994). The risk of respiratory complications has been
reported to be between 15% and 32.5% (D’Arsigny 1998; Wang
1999) and has been observed to account for more than half of the
30-day mortality after surgery to remove a lung (Powell 2009). In
the same observational study, cardiac arrhythmias were reported
in 20% of patients (Powell 2009). Pain relief after thoracic surgery
is therefore important for patient comfort and for reduction of
postoperative pulmonary and cardiac complications.
Pain can often persist after thoracotomy and the incidence of
chronic pain is high, with studies revealing that 30% to 50% of
patients still experience pain up to five years after surgery (De
Cosmo 2009; Rogers 2000). The exact mechanism of chronic
post-thoracotomy pain is unknown but intercostal nerve damage
at thoracotomy is believed to be a major factor, as demonstrated
by neurophysiological studies (Benedetti 1998). Electromyogra-
phy and somatosensory evoked responses demonstrated that in-
tercostal nerve damage led to a decreased pain threshold of the
operative scar. A ’wind up’ phenomenon of repeated stimulation
of peripheral nerve fibres can cause a wide range of nerve fibres
to become hyperexcitable and is associated with chronic pain. Ag-
gressive management of acute pain following thoracotomy may
reduce the likelihood of developing chronic pain (Katz 1996). A
multi-modal approach to analgesia is widely employed by thoracic
anaesthetists using a combination of regional anaesthetic blockade
and systemic analgesia, with both non-opioid and opioid medica-
tions and local anaesthesia blockade.
There is some evidence that blocking the nerves as they emerge
from the spinal column (paravertebral block) may be associated
with a lower risk ofmajor complications in thoracic surgery but the
majority of thoracic anaesthetists still prefer to use a thoracic epidu-
ral as analgesia for their patients undergoing thoracotomy. Previ-
ous systematic reviews of analgesic techniques in thoracic surgery
have only evaluated short-term complications (Davies 2006; Joshi
2008; Kotze 2009). In order to bring about a change in prac-
tice, anaesthetists need a review that evaluates the risk of all major
complications associated with thoracic epidural and paravertebral
block in thoracotomy.
Description of the intervention
Thoracic epidural blockade
Thoracic epidural blockade (TEB) using local anaesthetic and opi-
oid agents has been widely regarded as the gold standard for anal-
gesia and the reduction of associated complications following tho-
racotomy. Good analgesia from an epidural can result in early ex-
tubation, better ventilatory mechanics and gas exchange and re-
duced rates of lung collapse, pneumonia and pain (De Cosmo
2009). However, the technique requires highly trained medical
staff not only for insertion and removal of the epidural catheter
but also for the management of the continuous infusion of pain
medication. The risks associated with insertion of the epidural
include accidental dural puncture, inadvertent high block, local
anaesthetic toxicity and total spinal anaesthesia (inadvertent spinal
injection of an epidural dose of local anaesthetic leading to local
anaesthetic depression of the cervical spinal cord and the brain-
stem). Nerve injury, epidural haematoma and abscess are rare but
serious complications. The UK National Audit Project led by the
Royal College of Anaesthetists reported a low rate of permanent
harm from all central blocks of 4.2 per 100,000, with rates twice
as high in epidurals compared with other central neuraxial blocks
(Cook 2009). A thoracic epidural blocks nerves bilaterally and
sympathetic nerve block can result in hypotension due to both
vasodilatation and cardiac depression. This requires cautious fluid
administration in order to avoid fluid overload in susceptible pa-
tients (Marret 2005). Failure rates have been described as from
14% to 30% and can be influenced by the skills of the practitioner
inserting the catheter and accidental dislodgement of the catheter
(Davies 2006).
An epidural is not a suitable technique for all patients and is
contraindicated in patients with local infection, previous spinal
surgery, disorders of blood clotting and in those taking anti-coag-
ulant and anti-platelet therapy. The epidural is inserted through
the skin rather than placed under vision and requires a highly
skilled practitioner to perform the technique. Trained staff are also
needed to look after the patients postoperatively in order to avoid
accidental dislodgement of catheters and to observe for side ef-
fects. These staff add to the cost of the technique to the healthcare
system.
Paravertebral blockade
Paravertebral block (PVB) involves injecting local anaesthetic into
the paravertebral space to block nerves after leaving the spinal
cord. PVB can be given as a ’single shot’ technique but is often
given as a continuous infusion of local anaesthetic via a catheter
placed directly through the skin (percutaneously) or under direct
vision during thoracotomy. Thoracic paravertebral anaesthesia has
a number of advantages over the thoracic epidural technique. PVB
is a one-side (unilateral) technique and so respiratory and sympa-
thetic function is preserved on the other (contralateral) side (Ng
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2007) and this may be associated with less hypotension, fewer pul-
monary complications and less urinary retention (Davies 2006).
The failure rate in adults has been reported as 10.1% (Lonnqvist
1995; Richardson 1999) and significantly lower than TEB (odds
ratio (OR) 0.28, P value = 0.007) (Davies 2006). The compli-
cations reported include inadvertent vascular puncture (3.8% to
6.8%); hypotension (4.0% to 4.6%); haematoma (2.4%); pain at
site of skin puncture (1.3%); signs of epidural or intrathecal spread
(1.0%); pleural puncture (0.8% to 1.1%); and pneumothorax
(0.5%) (Lonnqvist 1995; Naja 2001). Recent evidence suggests
that short-term side effects such as hypotension, urinary retention,
nausea, and vomiting appear to be less frequent with PVB than
with TEB (Daly 2009). The effect of paravertebral anaesthesia on
blood pressure and heart rate is minimal, making this technique
safe for patients with coexisting circulatory disease. PVB is thought
to be associated with better pulmonary function and fewer pul-
monary complications than TEB (Joshi 2008; Richardson 1999).
Contraindications to thoracic epidural analgesia do not preclude
PVB, which can also be safely performed in anaesthetized patients
without an apparent increased risk of neurological injury.
How the intervention might work
The primary purpose of both these techniques is to achieve good
postoperative analgesia. They employ the same pharmacological
agents and both have been shown to produce important benefits
in this clinical setting. This review is less concerned with the mode
of action of PVB than with the ease of use, broad applicability,
and relative safety of this technique. Technically, PVB is easier to
perform than TEB, needle placement for paravertebral block is
away from the midline and spinal cord (Richardson 1999), and
some patients who are unsuitable for TEB may be suitable for
PVB.
Why it is important to do this review
TEB using local anaesthetic and opioid has been widely regarded
as the gold standard for analgesia and reduction of the associ-
ated complications after thoracotomy. A survey of Australian tho-
racic anaesthetists in 1997 revealed that 79% regarded TEB as
the method of choice for analgesia in thoracotomy (Cook 1997a).
Similar results were found in the UK, with 80% of anaesthetists
considering TEB as the best mode of pain relief for upper ab-
dominal surgery (Cook 1997b). Recent evidence from two meta-
analyses and systematic reviews comparing the analgesic efficacy
and side effects of epidural versus paravertebral blockade for tho-
racotomy pain control concluded that although the analgesia was
comparable, paravertebral blockade had a better short-term side-
effect profile, including urinary retention, hypotension, nausea
and vomiting, and pulmonary complications (Davies 2006; Joshi
2008). The reviews suggest that paravertebral blockade may be su-
perior to an epidural, but these reviews did not evaluate the more
serious complications including mortality. A 2008 survey of all 38
thoracic units in the UK that was carried out by the Association of
Cardiothoracic Anaesthetists (ACTA) reported that the majority
of thoracic anaesthetists (2/3 units) prefer TEB to PVB, which
suggests that most thoracic anaesthetists have yet to be convinced
by the evidence available (Shelley 2008).
Compared to TEB, PVB may have several practical advantages.
In patients on anti-coagulants or anti-platelet therapy, PVB can
be placed with little concern about epidural haematoma, abscess,
or neurological injury (Daly 2009; Luyet 2009). The catheter can
be placed in the correct position under the direct guidance of the
surgeon, ensuring accurate placement without damage to neu-
rovascular structures or the pleura. Postoperative management of
epidural infusion requires a specialized unit or ward whilst PVB
can be managed on an ordinary ward (Daly 2009; Luyet 2009).
PVB can be used in a higher proportion of patients and reduces
their hospital stay, thereby reducing costs as well as improving the
quality of patient care and satisfaction.
A large prospective multicentre investigation into analgesic tech-
niques and morbidity following elective pneumonectomy for can-
cer (Powell 2009) shows that TEB was associated with more ma-
jor complications, including significant arrhythmias or pulmonary
complications requiring treatment or ventilator support, unex-
pected intensive care unit (ICU) admissions, 30-day mortality,
further surgery, inotrope usage than PVB (OR adjusted for patient
and perioperative factors of 2.2, 95% confidence interval (CI) 1.1
to 3.8; P value = 0.02) (Powell 2009). A comprehensive review of
the existing evidence is needed to establish whether paravertebral
block is associated with a lower risk of major complications and
to clarify whether further randomized trials are justified.
O B J E C T I V E S
To compare the two regional techniques of TEB and PVB in adults
undergoing elective thoracotomy with respect to:
1. analgesic efficacy;
2. the incidence of major complications (including mortality);
3. the incidence of minor complications;
4. length of hospital stay;
5. cost effectiveness.
M E T H O D S
Criteria for considering studies for this review
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Types of studies
We included only randomized controlled trials (RCTs). We have
excluded quasi-randomized trials, for example where allocation
was determined by days of the week or hospital number.
Types of participants
We included all adults undergoing elective thoracotomy including
for upper gastrointestinal surgery.
Types of interventions
We included continuous thoracic epidural infusions using local
anaesthetics, opioids, and any adjuvant therapies. The comparator
was continuous paravertebral blockade using local anaesthetics and
adjuvant therapies.
Types of outcome measures
Primary outcomes
1. Mortality to 30 days.
2. Major complications including any of: cardiovascular
complications (systemic hypotension requiring inotropic
support, significant arrhythmias requiring anti-arrhythmic or
cardioversion treatment, myocardial infarction, pulmonary
oedema); pulmonary complications requiring treatment
(postoperative ventilatory support, reintubation for respiratory
failure, acute carbon dioxide retention (CO > 45 mmHg),
pneumonia, atelectasis); neurological complications (delirium);
unexpected admission to intensive care; any complications that
lead to further surgery.
Secondary outcomes
1. Analgesic efficacy including pain scores (visual analogue
scales), acute pain, failure of technique, supplemental analgesia,
morphine consumption.
2. Minor complications including hypotension (not requiring
inotropes), postoperative ileus, excessive sedation, nausea and
vomiting, pruritis, and urinary retention.
3. Chronic pain at six months and one year.
4. Duration of hospital stay and cost.
Search methods for identification of studies
Electronic searches
We searched for studies on thoracic epidural and paravertebral
blocks in adults undergoing thoracotomy in the Cochrane Cen-
tral Register of Controlled Trials (CENTRAL, 2013, Issue 9) see
Appendix 1); MEDLINE via Ovid (1966 to 16th October 2013,
see Appendix 2); EMBASE via Ovid (1980 to 16th October 2013,
see Appendix 3); and CINAHL via EBSCOhost (1982 to 16th
October 2013, see Appendix 4); trial reference lists; and in con-
ference abstracts.
We limited the results to RCTs using theCochrane highly sensitive
search strategy (Higgins 2011). We did not impose any language
restriction.
We combined a free-text search with a controlled vocabulary
search, from the inception of a database to the present.
We handsearched the Journal of Cardiothoracic Surgery and Journal
of Cardiothoracic and Vascular Anesthesia (from 1996 to 2013).
We reran the search on 31st January 2015. We found one study of
interest during that search which we will address when we update
the review.
Searching other resources
We searched conference proceedings and abstracts of important
meetings in cardiothoracic surgery and anaesthesia on 31st January
2015 and made all efforts to contact authors and experts in order
to identify any unpublished research and trials still underway.
We also searched the databases of ongoing trials on 31st January
2015, such as: www.controlled-trials.com/; clinicaltrials.gov/.
Data collection and analysis
Selection of studies
Two review authors (JY and SG) screened the abstracts of all pub-
lications obtained by the search strategies. We noted any reasons
for study exclusion in RevMan 5.3. For trials that appeared to be
eligible RCTs, we obtained the full articles to assess their relevance
based on the predefined criteria for inclusion. We resolved any
disagreement through discussion or, if required, we consulted with
FG.
Data extraction and management
We used a data collection form to extract data (see Appendix 5).
For eligible studies, two review authors (JY and SG) extracted data
independently from original publications onto the agreed form.
We resolved any disagreement through discussion or, if required,
we consulted with FG. As far as possible, we contacted study au-
thors for important information that was missing or unclear. We
entered data into RevMan 5.3 and checked it for accuracy.
Assessment of risk of bias in included studies
Two review authors (JY and SG) independently assessed the risk
of bias for each study using the criteria outlined in the Cochrane
’Risk of bias’ assessment tool (Higgins 2011). We resolved any
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disagreement through discussion or, if required, we consulted with
FG. We constructed a ’Risk of bias’ table for all included studies
in the review.
(1) Random sequence generation
We described for each included study the method used to generate
the random sequence in sufficient detail to allow assessment of
whether it should produce comparable groups.
We assessed the method as:
§ low risk of bias (any truly random process, e.g. random number
table, computerized random number sequence);
§ high risk of bias (inadequate generation of randomization se-
quence, e.g. consecutive);
§ unclear risk of bias.
(2) Allocation concealment (checking for possible selection
bias)
We described for each included study the method used to conceal
the allocation sequence in sufficient detail and determine whether
intervention allocation could have been foreseen in advance of or
during recruitment, or changed after assignment.
We assessed the methods as:
§ low risk of bias (e.g. telephone or central randomization; con-
secutively-numbered sealed opaque envelopes);
§ high risk of bias (e.g. open random allocation; unsealed or non-
opaque envelopes; alternation; date of birth);
§ unclear.
(3) Blinding (checking for possible performance bias)
We described for each included study the methods used, if any,
to blind the study participants personnel and outcome assessment
from knowledge of which intervention a participant received. We
judged studies to be at low risk of bias if they were blinded, or if we
judge that the lack of blinding could not have affected the results.
We recognized that it may not be possible to blind clinicians or
participants.
We assessed the methods as:
§ low risk of bias, high risk of bias, or unclear risk of bias for
participants;
§ low risk of bias, high risk of bias, or unclear risk of bias for
personnel;
§ low risk of bias, high risk of bias, or unclear risk of bias for
outcome assessors.
(4) Incomplete outcome data (checking for possible attrition
bias through withdrawals, dropouts, protocol deviations)
We described for each included study, and for each outcome or
class of outcomes, the completeness of data including attrition
and exclusions from the analysis. We stated whether attrition and
exclusions were reported, the numbers included in the analysis
at each stage (compared with the total number of randomized
participants), the reasons for attrition or exclusion where reported,
and whether missing data were balanced across groups or were
related to outcomes. Where sufficient information was reported,
or could be supplied by trial authors, we re-included missing data
in the analyses which we undertook.
We assessed the methods as:
§ low risk of bias (where numbers and reasons for attrition, ex-
clusion or re-inclusion have been reported);
§ high risk of bias (where there are high numbers of dropouts and
protocol deviations leading to loss to follow-up);
§ unclear.
(5) Selective reporting bias
Where the original protocol of a study was available (for example,
as a separate publication), we assessed whether all of the prespeci-
fied outcomes and analyses were presented.
We assessed the methods as:
§ low risk of bias (where it is clear that all of the study’s prespecified
outcomes and all expected outcomes of interest to the review have
been reported);
§ high risk of bias (where not all the study’s prespecified outcomes
have been reported, one ormore of the reported primary outcomes
were not prespecified, outcomes of interest were reported incom-
pletely and so cannot be used, the study fails to include results
of a key outcome that would have been expected to have been
reported);
§ unclear.
(6) Other bias
We described for each included study any important concerns we
have about other possible sources of bias.
We assessed whether each study was free of other problems that
could put it at risk of bias:
§ low risk of bias;
§ high risk of bias;
§ unclear.
(7) Overall risk of bias
We made explicit judgements about whether studies are at high
risk of bias, according to the criteria given in the Cochrane Hand-
book for Systematic Reviews of Interventions (Higgins 2011). With
reference to (1) to (6) above, we assessed the likely magnitude and
direction of the bias and whether we considered it likely to im-
pact on the findings. We explored the impact of the level of bias
through undertaking sensitivity analyses; see Sensitivity analysis.
Measures of treatment effect
Dichotomous data
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For dichotomous data, we have presented results as a summary
risk ratio (RR) with 95% confidence interval (CI).
Continuous data
For continuous data, we used the mean difference (MD) if out-
comes are measured in the same way between trials. When possi-
ble, we used the standardized mean difference (SMD) to combine
trials that measure the same outcome but use different methods.
Unit of analysis issues
Cluster-randomized trials
We had intended to include cluster-randomized trials in the anal-
yses along with individually randomized trials but we found no
suitable cluster-randomized trials.
Dealing with missing data
For included studies, we noted levels of attrition. We explored the
impact of including studies with high levels of missing data in the
overall assessment of treatment effect, using sensitivity analysis.
We performed sensitivity analysis for missing data by inclusion
and exclusion of studies with a high proportion of missing data.
We conducted sensitivity analysis by omitting studies with high
attrition (> 15% of participants) from analysis (Gulbahar 2010;
Perttunen 1995).We have described this in the Sensitivity analysis
section.
For all outcomes, we conducted analyses as far as possible on an
intention-to-treat (ITT) basis; that is, we attempted to include all
participants randomized in the analyses in the groups to which
they were allocated, regardless of whether or not they received the
allocated intervention.
Assessment of heterogeneity
If we detected substantial heterogeneity we considered whether a
pooled result would be meaningful and if so we used a random-
effects model analysis to produce it. We assessed statistical hetero-
geneity in each meta-analysis using the I² and τ ² statistics. We re-
garded heterogeneity as substantial if the I² statistic exceeded 30%
and either τ ² was greater than zero, there was a low P value (<
0.10) in the Chi² test for heterogeneity, or there was clearly sub-
stantial inconsistency between trials in the direction or magnitude
of effects as judged by visual inspection.
Assessment of reporting biases
If there were 10 or more studies in a meta-analysis we planned to
investigate reporting biases such as publication bias, using funnel
plots. We planned to assess funnel plot asymmetry visually and by
formal tests. For continuous outcomes we planned to use the test
proposed by Egger 1997, and for dichotomous outcomes the tests
proposed by Harbord 2006 or Peters 2006. If any of these tests
detected asymmetry or it was suggested by a visual assessment, we
planned to perform exploratory analyses to investigate it.
Data synthesis
We carried out statistical analysis using the ReviewManager 5 soft-
ware (RevMan 5.3). We used a fixed-effect model meta-analysis
for combining data where it was reasonable to assume that studies
are estimating the same underlying treatment effect, that is, where
trials were examining the same intervention and we judged the
trial populations and methods to be sufficiently similar. If there
was clinical heterogeneity sufficient to expect that the underlying
treatment effects differed between trials, or if we detected substan-
tial statistical heterogeneity, we used a random-effects model anal-
ysis to produce an overall summary, if we considered this clinically
meaningful. We presented the results of random-effects analyses
as the estimated average treatment effect with its 95% confidence
interval, and the 95% prediction interval for the underlying treat-
ment effect (Riley 2011). If an average treatment effect across trials
was not clinically meaningful we did not combine heterogeneous
trials. If we used random-effects analyses, the results presented re-
flect the average treatment effect and its 95% confidence interval,
the 95% prediction interval for the underlying treatment effect,
and the estimates of τ ² and I² statistic.
Subgroup analysis and investigation of heterogeneity
If we identified substantial heterogeneity, we planned to investigate
it using subgroup and sensitivity analyses.
We planned to consider whether an overall summary was mean-
ingful and if so to use a random-effects model analysis to produce
it. We planned to carry out the following subgroup analyses.
1. Different types of epidurals (e.g. local anaesthetics with or
without added opioid).
2. Different types of surgery (e.g. thoracic surgery, upper
gastrointestinal surgery).
3. Timing of insertion (before skin incision, after operation).
4. Method of insertion (blind, under ultrasound guidance,
under direct vision).
5. Other additives used in local anaesthetic mixture (beside
local anaesthetics and opiates).
We planned to use only the primary outcome (major complica-
tions) in subgroup analysis.
For fixed-effect inverse variance meta-analysis we planned to as-
sess the differences between subgroups by interaction tests imple-
mented in RevMan 5.3. For other types of analysis we planned to
conduct interaction tests using mixed-effects meta-regression in
external statistical software.
Sensitivity analysis
Weplanned to carry out sensitivity analysis to explore the effects of
fixed-effect or random-effects analyses for outcomeswith statistical
heterogeneity and the effects of any assumptions made such as
the value of the intracluster correlation coefficient (ICC) used
for cluster-randomized trials. There were no cluster-randomized
controlled trials in this review and the ICC was not calculated.We
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had also planned to use sensitivity analyses to explore the effects of
inclusion of studies at high risk of bias (by assessing the effects of
deletion of high-risk studies), and the effects of missing outcome
data (by assessing best-case and worst-case scenarios, and whether
plausible values of missing data are likely to make a substantial
difference to the results).
’Summary of findings’ tables
We used the principles of the GRADE system (Guyatt 2008) in
our review to assess the quality of the body of evidence associated
with specific outcomes. We included the following as outcomes:
cardiovascular complications, pulmonary complications, critical
care admission, further surgery, 30-day mortality, analgesia effi-
cacy, minor complications, and constructed a ’Summary of find-
ings’ table using the GRADEpro software. The GRADE approach
appraises the quality of a body of evidence based on the extent to
which one can be confident that an estimate of effect or associa-
tion reflects the item being assessed. The quality of a body of evi-
dence considers within-study risk of bias (methodologic quality),
the directness of the evidence, heterogeneity of the data, precision
of effect estimates, and risk of publication bias.
R E S U L T S
Description of studies
See Characteristics of included studies and Characteristics of
excluded studies.
Results of the search
See Figure 1
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Figure 1. 1 Study flow diagram (Search dates October 2013, reran January 2015)
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The electronic and handsearches described above and in the ap-
pendices in October 2013 retrieved 74 results. After removal of
one duplicate, there were 73 unique results. After review of the
abstracts we excluded 54 reports and reviewed the full-text version
of the remaining 19 citations. Of these, we considered 14 papers
to be relevant to the research question. We were unable to ob-
tain a full-text version of one paper (Wedad 2004), which remains
awaiting classification.
We reran the search on 31st January 2015 and found one study
of interest (Raveglia 2014). There are two studies in total that
are awaiting classification. We will address these studies when we
update the review.
Included studies
We include 14 studies (Bimston 1999; Casati 2006; De Cosmo
2002; Grider 2012; Gulbahar 2010; Ibrahim 2009; Kaiser 1998;
Kobayashi 2013;Matthews 1989;Messina 2009;Murkerjee 2010;
Perttunen 1995; Pintaric 2011; Richardson 1999) involving a to-
tal of 698 participants in qualitative and quantitative analyses. In-
cluded studies were from 1995 to 2003, and of relatively small
sample sizes, ranging from20 to 100 participants. There was a high
degree of clinical heterogeneity. Whilst all 14 studies compared
the analgesic efficacy of paravertebral blockade (PVB) and thoracic
epidural blockade (TEB) in participants undergoing open thora-
cotomy, there were significant differences in the timing, method
of insertion and utilization of PVB and TEB in the peri-opera-
tive setting (Table 1). In the majority of the studies, TEB was in-
serted at the beginning of the procedure before surgical incision
was made, except for Matthews 1989 where the participants were
randomized to the intervention at the end of the procedure and
TEB was then placed by the anaesthetists after chest closure. Al-
though TEBs were inserted before the surgical procedure in the
remaining 13 studies, these were not used to provide pain relief
until the end of surgery in five studies (Grider 2012; Kobayashi
2013;Messina 2009;Murkerjee 2010; Perttunen 1995). The time
frames for data collection and follow-up of participants ranged
from two to 96 hours postoperatively.
There was further heterogeneity in the placement of PVB. In three
studies (Casati 2006; Messina 2009; Richardson 1999), the par-
avertebral space was identified using landmark technique, and lo-
cal anaesthetic was injected as a bolus to initiate the blockade.
The most popular insertion method of PVB catheter was by the
surgeon under direct vision, and eight studies used this technique
(Bimston 1999; De Cosmo 2002; Grider 2012; Gulbahar 2010;
Kaiser 1998; Kobayashi 2013; Perttunen 1995; Richardson 1999).
PVB catheters were inserted by anaesthetists percutaneously be-
fore surgical procedure in five studies (Casati 2006; Ibrahim 2009;
Messina 2009; Murkerjee 2010; Pintaric 2011) and post-proce-
dure in one study (Matthews 1989).
The content of infusions used for TEB and PVB also varied in
terms of timing and volume of boluses/loadingdose, infusion rates,
local anaesthetic used (bupivacaine, levobupivacaine, ropivacaine),
concentration of local anaesthetic (0.1% to 0.5%), whether opi-
ates were added and what type of opiates (fentanyl, morphine,
hydromorphine) (see Table 1). For further details refer to the
Characteristics of included studies tables.
Excluded studies
There were three excluded studies (Elsayed 2012; Kanazi 2012;
Kozar 2011). Elsayed 2012 was a retrospective analysis of patient
records looking at complications in post-thoracotomy patients.
Kanazi 2012 described a subpleural catheter but without review
of described technique, and did not represent a PVB so was ex-
cluded. Although Kozar 2011 compared thoracic epidural and
paravertebral block and the incidence of chronic pain, pain was
measured at three months and did not meet our selection criteria.
Data were not included in our analysis. For further details refer to
the Characteristics of excluded studies tables.
Studies awaiting classification
There are two studies awaiting classification. Wedad 2004 com-
pared thoracic epidural, paravertebral and interpleural analgesia
with wound infiltration. Despite strenuous efforts, we did not
manage to obtain a copy of the article to include in our review.
Raveglia 2014 was a prospective randomized study of 71 partici-
pants undergoing thoracotomy, comparing the impact of thoracic
epidural and paravertebral blockade on pain control and respira-
tory function. For further details refer to the Characteristics of
studies awaiting classification tables.
Ongoing studies
There are no ongoing studies
Risk of bias in included studies
See Figure 2 and Figure 3 for summaries of the ’Risk of bias’
assessments for the 14 included studies.
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
The majority of studies did not report how the randomization
sequence was generated, simply saying that allocation was “ran-
dom”. Six studies reported the randomization method used and
were at low risk of selection bias (Bimston 1999; Casati 2006; De
Cosmo 2002; Ibrahim 2009; Pintaric 2011; Richardson 1999).
Three studies reported adequate methods of allocation conceal-
ment and were at low risk of selection bias (Casati 2006; Ibrahim
2009; Pintaric 2011). The majority dd not mention how the ran-
dom sequence was applied, or whether allocations were adequately
concealed before assignment.
Blinding
Two studies reported blinding of participants and clinicians and
were at low risk of performance bias (Grider 2012; Ibrahim 2009).
This was achieved by putting both types of analgesia in place but
only infusing one. The remainder of the studies either stated that
participants and clinicians were aware of treatment allocations,
or did not mention blinding, which probably means they were
not blinded. Four studies described measures to blind observers
of outcomes and were at low risk of detection bias (Grider 2012;
Casati 2006; Ibrahim 2009; Pintaric 2011). In most studies, the
main outcomes were self-reported by the participants, who were
not blinded.
Incomplete outcome data
Ten studies reported outcomes for all randomized participants and
were at low risk of attrition bias (Bimston 1999; Casati 2006;
Grider 2012; Ibrahim 2009; Kobayashi 2013; Matthews 1989;
Messina 2009;Murkerjee 2010; Pintaric 2011; Richardson 1999).
There was no study reporting high levels of missing data (less than
15% in all cases). However, we rated two studies at high risk of
bias: Gulbahar 2010 excluded 6/50 participants (12%), but all
from the epidural arm; Perttunen 1995 excluded 6/51 randomized
participants (12%). We examined the treatment effects according
to quality components (concealed treatment allocation, blinding
of participants and caregivers, blinded outcome assessment).
Selective reporting
None of the included studies was registered on trial registries and it
was unclear whether there was selective reporting bias. In one study
(Messina 2009), several potentially important outcome measures
were not published, including VAS on movement, sedation scores
and arterial blood gases.
Other potential sources of bias
Six studies had low risk of other bias (Casati 2006; De Cosmo
2002; Ibrahim 2009; Kobayashi 2013; Perttunen 1995; Pintaric
2011). In Bimston 1999 the two arms were treated differently;
the epidural arm was under the care of anaesthetists, but the par-
avertebral block arm was under the care of the surgical team. This
led to differences in the care received, and hence differences in
outcome may be due to differences in treatments received other
than the randomized intervention. In Messina 2009, the authors
stated that their institution had extensive experience in the inser-
tion of TEB catheters but the insertion of PVB catheters was a
novel technique to the anaesthetists who had only performed 30
PVBs prior to the study. The differences in the analgesic efficacy
of the two techniques, especially PVB, could be influenced by the
disparity in experience.
Effects of interventions
See: Summary of findings for the main comparison
Paravertebral blockade compared to thoracic epidural blockade
for patients undergoing thoracotomy (30-daymortality andmajor
complications); Summary of findings 2 Paravertebral blockade
compared to thoracic epidural blockade for patients undergoing
thoracotomy (acute pain)
Primary outcomes
1. Mortality at 30 days
There was low-quality evidence on mortality at 30 days, with only
two studies reporting 30-day mortality (Kaiser 1998; Richardson
1999), and a total of 125 participants (17.9% of total participants
included in this review). Five out of 61 (8.2%) participants died
in the PVB group and four out 64 (6.3%) participants died in
the TEB group, an absolute risk reduction of 1.9%. The risk of
dying within 30 days following PVB was not statistically higher
(RR 1.28, 95% CI 0.39 to 4.24, P value = 0.68) (Analysis 1.1)
2. Major complications
We had intended to report the overall risk of suffering a major
complication with each of the techniques under study; however,
none of the included studies reported the number of individuals
who suffered a major complication. Rather, they each reported the
number of individuals with each individual complication, and it
is not clear how many such complications each individual may
have suffered. We have therefore reported here on each major
complication individually.
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Cardiovascular complications
There was low-quality evidence on major cardiovascular com-
plications, with limited data available. Two studies with a total
of 114 participants (16.3% of total participants included in this
review) reported cardiovascular complications (Matthews 1989;
Richardson 1999); 2/56 (3.6%) had cardiovascular complications
following PVB, while 4/58 (6.9%) reported the same in the TEB
group. There was no difference in hypotension requiring inotropes
(RR 0.30, 95% CI 0.01 to 6.62, P value = 0.45), arrhythmias (RR
0.36, 95%CI 0.04 to 3.29, P value = 0.36) and myocardial in-
farction (RR 3.19, 95% CI 0.13 to 76.42, P value = 0.47), Figure
4. In Matthews 1989, one participant in the TEB group suffered
persistent hypotension despite fluid resuscitation and received in-
otropic support (RR 0.30, 95% CI 0.01 to 6.62, P value = 0.45),
Analysis 2.1. Three participants from the TEB group and one
participant from the PVB group developed arrhythmias but there
was no information on the treatment that they received (RR 0.36,
95% CI 0.04 to 3.29, P value = 0.36, Analysis 2.1). Richardson
1999 reported one participant in the PVB group who had a my-
ocardial infarction and died as a result (RR 3.19, 95% CI 0.13 to
76.42, P value = 0.47, Analysis 2.1).
Figure 4. Forest plot of comparison: 2 Major complications, outcome: 2.1 Cardiovascular complications.
Pulmonary complications
There was low-quality evidence on pulmonary complications. Five
studies with a total of 280 participants (40.1% of total) reported
pulmonary complications (Bimston 1999; Grider 2012; Kaiser
1998; Perttunen 1995; Richardson 1999). Eleven of 131 (8.4%)
participants in the PVB group reported respiratory complications,
while 20/149 (13.4%) reported the same in the TEB group. This
difference of 5% was not statistically significant (RR 0.62, 95%
CI 0.26 to 1.52, I² statistic = 26%, P value = 0.30, Figure 5). In
subgroup analyses by specific complications reported, there was
no statistically significant difference between the PVB and TEB
groups. Two participants from the TEB group developed respira-
tory distress and were reintubated and ventilated in the intensive
care unit (ICU) in Grider 2012.
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Figure 5. Forest plot of comparison: 2 Major complications, outcome: 2.2 Respiratory complications.
In Perttunen 1995, respiratory depression (PaCO >4.5 kPa) was
observed in five participants in the TEB group and six participants
in the PVB group for more than two hours after the operation.
Pneumonia was diagnosed in participants from three studies, in 18
out of 175 participants (Bimston 1999; Kaiser 1998; Richardson
1999). The risk of developing pneumonia post-thoracotomy was
not significantly different between the PVB and TEB groups (RR
0.38, 95% CI 0.10 to 1.45, I² statistic = 28%, P value = 0.16,
Analysis 2.2). Atelectasis was not observed in our included studies.
Neurological complications
Major neurological complications were poorly reported. There
was moderate-quality evidence on delirium only.Deliriumwas de-
scribed in two clinical trials involving 125 participants (Perttunen
1995; Richardson 1999) but no definition of delirium was re-
ported.
In Perttunen 1995, seven out of 15 participants developed delir-
ium in the TEB group compared to two out of 15 participants in
the PVB group. Three out of 49 participants in the TEB group de-
veloped delirium compared with one out of 46 participants in the
PVB group in Richardson 1999. The risk of developing delirium
following thoracotomy was lower in the PVB group compared to
TEB, but did not reach statistical significance (RR 0.31, 95% CI
0.09 to 1.00, P value = 0.05, Analysis 2.3).
Unexpected admission to intensive care
There was low-quality evidence on unexpected admission to in-
tensive care with very limited data from two studies of 139 partic-
ipants (Gulbahar 2010; Richardson 1999). Three out of 25 par-
ticipants in the TEB group were admitted to the ICU compared
to one out of 25 participants in the PVB group in Gulbahar 2010.
Three participants each from both the TEB and PVB groups were
admitted to ICU unexpectedly in Richardson 1999. There was
little heterogeneity and fixed-effect analysis was used. Unexpected
admission rates to ICU were not statistically significant between
the PVB and TEB groups (RR 0.63, 95% CI 0.19 to 2.07, P value
= 0.44) Analysis 2.4.
Any complications that lead to further surgery
There was very low-quality evidence on complications that lead to
further surgery, with only one study of 45 participants (Perttunen
1995). In Perttunen 1995, one out of 15 participants in the TEB
group needed further surgery (RR 0.31, 95% CI 0.01 to 8.28).
Secondary outcomes
1. Analgesic efficacy including pain scores
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Although all 14 included studies reported on analgesic efficacy
of PVB and TEB, studies differed significantly in the way acute
pain was assessed and reported. Pooling of results from all studies
was not possible, due to significant clinical heterogeneity. Visual
analogue scale scores (VAS) were used in all of the studies but
the scales were different; a majority of studies used the 0 to 10
scale, but Kaiser 1998 used VAS in 0 to 4 categories (reported
as mean and standard deviation (SD)), and two studies (Ibrahim
2009; Perttunen 1995) used VAS 0 to 5. Types and concentrations
of local anaesthetic used in bolus and infusions also varied, with
some studies adding opiates to the infusion mixture and some
allowing participant-controlled top-up (see Table 1).The method
and time intervals of VAS score assessments also differed between
the studies, with somemeasuringVAS at rest and some at coughing
or on movement, with intervals ranging from every two to four
hours to only once every 24 hours (see Table 2). No subgroup
analysis was possible.
Findings from all the studies are summarized in Table 2. Due to
clinical heterogeneity and lack of reported data, we were only able
to extract data from six studies with a total of 239 participants
(DeCosmo 2002; Grider 2012; Kobayashi 2013;Matthews 1989;
Messina 2009; Pintaric 2011) for meta-analysis of VAS scores.
Due to the heterogeneity of the studies, we used the random-
effects model to analyse standardized mean difference between the
VAS scores of the PVB and TEB groups at each time point. We
found no significant differences in analgesic efficacy of TEB and
PVB in terms of VAS scores (on coughing/after physiotherapy) at
any time points (see Table 3); we also calculated 95% prediction
intervals to determine the distribution of values and underlying
treatment effect. Because there were few trials in the analyses, the
estimates of the treatment effects were imprecise, as shown by the
95% prediction intervals. The results were also statistically non-
significant.
Acute pain at two to six hours
There was moderate-quality evidence on acute pain at two to six
hours. Six studies with 365 participants were included (De Cosmo
2002; Grider 2012; Kobayashi 2013; Matthews 1989; Messina
2009; Pintaric 2011). Comparing VAS scores at two to six hours at
rest and on coughing/after physiotherapy, there was no statistically
significant difference between the PVB and TEB groups (SMD
0.35, 95% CI -0.09 to 0.78, P value = 0.12, Analysis 3.1).
Acute pain at 24 hours
There was moderate-quality evidence on acute pain at 24 hours.
Six studies with 365 participants have been included (De Cosmo
2002; Grider 2012; Kobayashi 2013; Matthews 1989; Messina
2009; Pintaric 2011). Comparing VAS scores at 24 hours at rest
and on coughing/after physiotherapy, there was no statistically
significant difference between PVB and TEB groups (SMD 0.02,
95% CI -0.24 to 0.28, P value = 0.90, Analysis 3.2).
Acute pain at 48 hours
There was moderate-quality evidence on acute pain at 48 hours.
Five studies with 346 participants have been included (De Cosmo
2002; Grider 2012; Kobayashi 2013; Pintaric 2011; Messina
2009). ComparingVAS scores at 48 hours at rest and on coughing/
after physiotherapy, there was no statistically significant difference
between the PVB and TEB groups (SMD 0.02, 95% CI -0.26 to
0.30, P value = 0.90, Analysis 3.3).
The remaining studies where we were unable to pool the reported
results in themeta-analyses are summarized below,while the results
of each are given in Table 2.
Four studies found PVB as effective as TEB in the postoperative
period (Casati 2006; Gulbahar 2010; Ibrahim 2009; Perttunen
1995).
Casati 2006 was a single-centre study carried out in Italy. Forty-
two consecutive participants undergoing elective thoracotomy for
lung lobectomy were randomized into two groups, with 21 par-
ticipants in the TEB group and 21 participants in the PVB group.
Participants were followed up for 48 hours postoperatively: max-
imal drop in systolic blood pressure was recorded for each group,
along with daily oxygenation and 12-hourly record of VAS.
Gulbahar 2010 recruited 50 participants scheduled for elective
thoracotomy in a single-centred RCT in Turkey. Data from 25
participants were collected from the PVBgroup but only data from
19 out of 25 participants were analysed from the TEB group, due
to catheter misplacement and early cessation of TEB blockade.
The study team collected VAS scores from participants for three
days post-surgery as well as oxygen saturation, pulse rate, blood
pressure, arterial blood gases and spirometry values.
Perttunen 1995 had three arms; 51 thoracotomy participants were
randomly assigned to receive single-shot intercostal blockade, con-
tinuous TEB or continuous PVB as analgesia. Only the results in
the TEB and PVB groups were analysed in this review. Partici-
pants were followed up for 48 hours post-surgery and pain was
assessed with regular VAS scores at rest and when coughing. Seg-
mental spread of sensory block in each group was recorded, as were
morphine consumption, plasma bupivacaine, arterial blood gases,
respiratory function tests and respiratory rate.
Ibrahim 2009 recruited 50 participants scheduled for elective tho-
racotomy, with 25 participants assigned to each group. Intra-oper-
ative pulse rate and blood pressure were recorded and participants
were followed up for 24 hours post-surgery. The extent of sensory
block and VAS scores were collected from both groups every four
hours. Additional data were collected also for plasma cortisol and
glucose levels, respiratory function tests and number of complica-
tions observed.
Three studies reported better pain relief with PVB than TEB (
Kaiser 1998; Murkerjee 2010; Richardson 1999).
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Kaiser 1998 recruited 30 participants who were undergoing tho-
racotomy in a single-centred RCT in Switzerland. Fifteen partici-
pants were allocated to each group. and they did not differ signif-
icantly in terms of age, gender, type and duration of surgical pro-
cedures and pre-operative respiratory function. Participants were
followed up for five days after surgery and data on daily VAS scores,
consumption of opioid analgesics, respiratory function tests and
plasma level of bupivacaine were collected. The study found PVB
to be as effective as TEB in acute pain control and also evidence
that reported that PVB provided better pain relief on days two
and three post-surgery than TEB
Murkerjee 2010 was a single-centred study carried out in India
which recruited 60 thoracotomy participants. Thirty participants
each were randomly allocated to the TEB and PVB groups. The
effectiveness of the two regional techniques was assessed by the
duration of analgesia from the initial bolus, and the time point
when a participant requested additional pain relief was recorded
as the end of the trial. The study found that single bolus PVB
provided statistically significantly longer duration of pain relief
compare with TEB (PVB mean 171.66 min (SD 77.31) versus
TEB mean 105.83 min (SD 33.28), P value < 0.0001).
Richardson 1999 was the largest study, with 100 participants. In
five participants, the insertion of a TEB catheter was not possible
and they were excluded from the study, leaving 49 participants in
the TEB group and 46 participants in the PVB group. VAS scores
were collected both at rest and on coughing, along with respiratory
function tests, oxygen saturation, plasma level of cortisol and glu-
cose. The study concluded that the analgesic efficacy of PVB was
superior to TEB with statistically significantly lower VAS scores
both at rest and on coughing (P value = 0.02 and P value = 0.0001
respectively).
Only one study provided evidence that TEB provided superior
analgesia compared to PVB. Bimston 1999 was a single-centre
study that recruited 50 participants. All participants were followed
up for four days during their hospital stay. The respiratory func-
tion of participants was assessed by forced expiratory volume over
one second (FEV ) and forced vital capacity (FVC) measured
pre-operatively, at one hour, eight hours, 24 hours, 48 hours and
72 hours after surgery. Serum levels of bupivacaine and fentanyl
were measured every six hours post-surgery until 72 hours. VAS
scores were recorded every eight hours after the operation until 96
hours.It was the only study to conclude that TEB was superior to
PVB. Statistically significantly higher VAS scores were found in
the PVB group for the first 40 hours, after which differences in
quality of analgesia was no longer significant.
Failure of technique
Failure of technique was often not reported as an outcome, but
was included as part of general results or the description of meth-
ods. There was moderate-quality evidence on failure of technique.
Four studies with 199 participants reported number of partici-
pantswhere inserted technique had failedwere included (Gulbahar
2010; Kaiser 1998; Perttunen 1995; Richardson 1999). There was
little heterogeneity and fixed-effect analysis was used. Our analy-
sis suggests there was a lower risk of failure of technique in par-
ticipants receiving PVB, which was statistically significant. The
failure rate was 1.98% (two events in 101 participants) for PVB
while the rate for TEB was 11.22% (11 events in 98 participants
) (RR 0.27, 95% CI 0.09 to 0.86, P value = 0.03, Analysis 3.4)
In Gulbahar 2010, it was not possible to insert a TEB catheter
in two out of 19 participants; all 25 PVB catheters were inserted
successfully. Perttunen 1995 reported similar findings, with two
out of 15 participants in the TEB group unable to have catheters
sited and none reported from the PVB group.
In Richardson 1999,TEB catheter insertion was also unsuccessful
in five out of 49 participants in the TEB group compared with
none from the PVB group.
Kaiser 1998 was the only study in which both TEB and PVB
catheters were misplaced (two from each group of 15 participants
respectively).
Supplemental analgesia consumption
The use of supplemental analgesia was not reported in detail by
the included studies. Types of additional analgesia included opi-
ates and non-steroidal anti-inflammatory medication (NSAIDs).
There were insufficient data for meta-analysis and we have pro-
vided a narrative description in this review.
In Casati 2006, only the number of participants requiring rescue
morphine analgesia was reported, and this was found to be similar
between the two groups (4/21 TEB versus 5/21 PVB, P value =
0.99).
De Cosmo 2002 reported no statistically significant difference
between mean ketolorac consumption between the PVB and TEB
groups (mean 72 (SD 26.5 mg) PVB versus mean 75.8 (SD 28.8
mg) TEB).
In Grider 2012, morphine patient-controlled analgesia (PCA) was
prescribed for participants if it was felt that a regional technique
failed to provide adequate analgesia. There were significantly more
participants that required PCA in the PVB (local anaesthetic only)
group compared to the other two groups (5/23 PVB, 3/18 TEB,
1/24 TEB with added opiate, P value < 0.05).
Gulbahar 2010 and Perttunen 1995 reported no statistical dif-
ference in mean cumulative morphine consumption between the
PVB and TEB groups.
Kaiser 1998 reported lower nicomorphine administration in the
PVB group compared with TEB, which reached statistical signif-
icance on postoperative day two.
In Kobayashi 2013, additional analgesia was only given to partic-
ipants if VAS was greater than 6 mm, but the type of analgesic
given was not specified. The authors recorded the frequency in the
administration of additional analgesics and found no statistically
significant difference between the TEB and PVB groups at any
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time points (Days 0, one and two).
Messina 2009 found statistically significantly higher cumulative
morphine consumption in the PVB group compared to TEB (me-
dian 36, interquartile range (IQR) 22 to 42 mg PVB versus me-
dian 9, IQR 2 to 22 mg TEB).
Pintaric 2011 reported comparable mean consumption of pir-
itramide (synthetic opioid) between the PVB and TEB groups
with no statistically significant difference at six, 24 and 48 hours
after surgery.
Similar results were also seen in Richardson 1999, where cumu-
lative morphine consumption was statistically significantly lower
in the PVB group in the first and second 24-hour period (mean
85.5 (SD 30) mg PVB versus 105.8 (SD 20.4) mg TEB; P value
= 0.008 and mean 210.7 (SD 63.8) mg PVB versus 262 (SD 67)
mg TEB; P value = 0.005 respectively).
2. Minor complications
In this review, the included studies did not provide enough data
to allow for pooling of results. Although the number of partici-
pants who developed a minor complication was reported in some
studies, it was unclear whether these participants developed one
or multiple complications. We have collated all available data and
have separately analysed the risk of developing minor complica-
tions.
Hypotension (not requiring inotropes)
Hypotension was the most commonly reported minor complica-
tion, with eight included studies reporting episodes of low blood
pressure that did not require inotropic support. Bimston 1999
described postural hypotension in one participant each from the
TEB and PVB groups, with no statistically significant differences
between the two groups. All other studies reported hypotension
in the TEB group only.
Casati 2006 defined hypotension as a drop of more than 30%
from baseline blood pressure. Four out of 21 participants in the
TEB group suffered hypotension compared with no participants
in the PVB group (P value = 0.04).
In Grider 2012, three participants in the TEB group suffered per-
sistent hypotension on postoperative day two and received local
anaesthetic infusion of lower concentration, and no reported hy-
potension in the PVB group.
Similarly in Gulbahar 2010, two participants from the TEB group
had their epidural infusions stopped temporarily due to persistent
hypotension,whereas noparticipants from the PVBgroup suffered
hypotension.
Ibrahim 2009 recorded regular blood pressure reading intra-op-
eratively and postoperatively. Mean arterial pressure in the TEB
group was significantly lower than that in the PVB group 20 min-
utes after injection of lower anaesthetic through infusion catheters
and persisted until 10 hours after surgery.Hypotention (more than
30% decrease from baseline) was found in six participants from
the TEB group and none from the PVB group.
Kobayashi 2013 described hypotension requiring the use of vaso-
pressor in two out of 35 participants (PVB group) compared to
five out of 35 participants (TEB group).
In Matthews 1989, hypotension was defined as a drop of 30
mmHg from baseline blood pressure recording. One participant
from the TEB group was withdrawn from the study due to in-
tractable hypotension and six further participants (out of a total of
nine) suffered hypotension. No participants from the PVB group
were found to be hypotensive.
Richardson 1999 described postoperative hypotension requiring
cessation of infusion in seven out of 49 participants receiving
epidural analgesia. There was no postoperative hypotension in par-
ticipants receiving paravertebral analgesia.
There was moderate-quality evidence on hypotension. Data were
available from eight included trials (Bimston 1999; Casati 2006;
Grider 2012; Gulbahar 2010; Ibrahim 2009; Kobayashi 2013;
Matthews 1989; Richardson 1999) in a total of 445 participants.
Overall, the risk of hypotension was significantly lower in the PVB
group compared to TEB (RR 0.16, 95% CI 0.07 to 0.38, P value
< 0.0001, Analysis 4.1).
Hypotension was not reported in Pintaric 2011 as fluid manage-
ment of participants was protocolized to achieve desired oxygen
delivery index (DO I) of more than 500 ml/min/m² by using
colloid boluses (to optimize intravascular volume status), infusion
of dobutamine (inotrope) and boluses of vasopressor. It was in-
teresting to note that a significantly higher volume of colloid was
required to achieve DO I in the TEB group compared with the
PVB group (TEB 554 ml, 95% CI 456 to 652 versus PVB 196
ml, 95% CI 49 to 343, P value = 0.04). Higher doses of vasopres-
sor were also required in the TEB group compared with the PVB
group (TEB 40 µg, 95% CI 21 to 59 versus PVB 17 µg, 95% CI
8 to 25, P value = 0.04). These results suggest that the effect of
TEB on the cardiovascular system was greater than PVB.
Postoperative ileus, nausea and vomiting
Postoperative ileus was not reported in any included studies. We
defined nausea and vomiting as any report of either nausea or vom-
iting in the study participants. Our analysis found that the risk of
nausea or vomiting was significantly lower in PVB (RR 0.48, 95%
CI 0.30 to 0.75, I² statistic = 0%, P value = 0.001, Analysis 4.2).
There was moderate-quality evidence. Six studies with a total of
345 participants (49.4% of the total) reported postoperative nau-
sea and vomiting (Bimston 1999;DeCosmo 2002; Ibrahim 2009;
Kobayashi 2013; Perttunen 1995; Richardson 1999). Twenty-
three of 176 (13.1%) participants had nausea or vomiting follow-
ing PVB, while 45/169 (26.6%) participants reported the same in
the TEB group.
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Excessive sedation
We defined excessive sedation as any report of change in mental
status, drowsiness or somnolence. There was moderate-quality ev-
idence on excessive sedation. Three included studies with a total of
175 participants documented excessive sedation (Bimston 1999;
Perttunen 1995; Richardson 1999). Our analysis found that the
risk of excessive sedation was lower in the PVB group compared
with the TEB group but this was not statistically significant (RR
0.84, 95% CI 0.57 to 1.24, P value = 0.39, Analysis 4.3)
Pruritis
There was moderate-quality evidence on pruritis. Five included
studies with 249 participants described pruritis as a minor compli-
cation from regional anaesthesia (Bimston 1999; DeCosmo 2002;
Grider 2012; Gulbahar 2010; Perttunen 1995), and all reported
higher incidence in the TEB group. Our analysis showed that the
risk of developing pruritis was statistically significantly lower in
the PVB compared to the TEB group (RR 0.29, 95% CI 0.14 to
0.59, P value = 0.0005, Analysis 4.4).
Urinary retention
There was moderate-quality evidence on urinary retention. Uri-
nary retention requiring bladder catheterization was noted in five
included studies with 258 participants (Bimston 1999; De Cosmo
2002; Gulbahar 2010; Matthews 1989; Richardson 1999), all re-
porting higher incidence of urinary retention in the TEB groups
compared with the PVB groups. The risk of urinary retention was
statistically significantly lower in the PVB compared to the TEB
group (RR 0.22, 95% CI 0.11 to 0.46, P value < 0.0001, Analysis
4.5).
3. Chronic pain at six months and one year
The incidence of chronic pain was very poorly reported, with two
studies describing participants complaining of pain after hospi-
tal discharge (Grider 2012; Richardson 1999). Participants from
Grider 2012 were followed up at 12 months, and 11 participants
complained of ongoing chest pain. Six participants were described
as suffering from intercostal neuralgia (two from the PVB group
and four from the TEB group) and four participants had malig-
nancy-related pain (one from the PVB group and three from the
TEB group).
At six-month follow-up, 10 participants from the TEB group re-
ported persistent burning chest pain compared to three partici-
pants from the PVB group in Richardson 1999. The chronic pain
in these participants was not related to tumour recurrence or in-
fection. There were insufficient data for statistical analysis.
4 Duration of hospital stay and cost
Duration of hospital stay was reported in six included studies,
with no statistically significant differences between the interven-
tion groups (Bimston 1999; De Cosmo 2002; Gulbahar 2010;
Kaiser 1998; Perttunen 1995; Richardson 1999). Three small
studieswith a total of 124participants (De Cosmo 2002;Gulbahar
2010; Kaiser 1998) reported similar duration of hospital stay be-
tween the PVB and TEB groups (MD -0.41 days, 95% CI -1.54
to 0.72, P value = 0.48, Analysis 5.1). Their results concurred
with three other included studies (Bimston 1999; Perttunen 1995;
Richardson 1999), which reported median duration of stay (see
Table 4). There was no statistically significant difference in dura-
tion of hospital stay between the PVB and TEB groups.
No included studies collected data on costs associated with each
intervention.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Paravertebral blockade compared to thoracic epidural blockade for patients undergoing thoracotomy (acute pain)
Patient or population: Patients undergoing thoracotomy
Settings: In hospitals, worldwide
Intervention: Paravertebral blockade
Comparison: thoracic epidural blockade
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Thoracic epidural block-
ade (TEB)
Paravertebral blockade
(PVB)
VAS score at 2 - 6 hours
(at rest)
Score from 0 - 10
The mean VAS score
ranged across TEB
groups from 1.0 to 3.4
The SMD VAS score at 2
- 6 hours (at rest) in the
PVB groups was
0.32 higher
0.30 lower to 0.94 higher 239
(6 studies)
⊕⊕⊕©
moderate1
Lower VAS score repre-
sents less pain and better
pain control
VAS score at 2 - 6 hours
(on coughing/after phys-
iotherapy)
Score from 0 - 10
The mean VAS score
ranged across TEB
groups from 2.2 to 3.4
The SMD VAS score at 2
- 6 hours (on coughing/
after physiotherapy) in the
PVB groups was
0.41 higher
0.20 lower to 1.03 higher 126
(3 studies)
⊕⊕⊕©
moderate1
Lower VAS score repre-
sent less pain and better
pain control
VAS score at 24 hours
(at rest)
Score from 0 - 10
The mean VAS score
ranged across TEB
groups from 1.0 to 3.0
The SMD VAS score at
24hours (at rest) in the
PVB groups was
0.16 higher
0.17 lower to 0.48 higher 239
(6 studies)
⊕⊕⊕©
moderate1
Lower VAS score repre-
sent less pain and better
pain control
VAS score at 24 hours
(on coughing/after phys-
iotherapy)
Score from 0 - 10
The mean VAS score
ranged across TEB
groups from 2.6 to 3.7
The SMD VAS score at 24
hours (on coughing/after
physiotherapy) in the PVB
groups was
0.23 lower
0.58 lower to 0.12 higher 126
(3 studies)
⊕⊕⊕©
moderate1
Lower VAS score repre-
sent less pain and better
pain control
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VAS scores at 48 hours
(at rest)
Score from 0 - 10
The mean VAS score
ranged across TEB
groups from 1.3 to 3.5
The SMD VAS scores at
48 hours (at rest) in the
PVB groups was
0.12 lower
0.46 lower to 0.22 higher 220
(5 studies)
⊕⊕⊕©
moderate1
Lower VAS score repre-
sent less pain and better
pain control
VAS scores at 48 hours
(on coughing/after phys-
iotherapy)
Score from 0 - 10
The mean VAS score
ranged across TEB
groups from 2.1 to 3.6
The SMD VAS scores at
48 hours (on coughing/
after physiotherapy) in the
PVB groups was
0.25 higher
0.16 lower to 0.66 higher 126
(3 studies)
⊕⊕⊕©
moderate1
Lower VAS score repre-
sent less pain and better
pain control
Failure of technique
(Number of participants)
Study population RR 0.27
(0.09 to 0.86)
199
(4 studies)
⊕⊕⊕©
moderate1
Lower failure technique
indicates more blocks in-
serted successfully112 per 1000 30 per 1000
(10 to 97)
Moderate
119 per 1000 32 per 1000
(11 to 102)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio; SMD: Standardized mean difference
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1Studies downgraded due to performance and detection bias.
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D I S C U S S I O N
Summary of main results
The limited evidence demonstrated no difference between PVB
and TEB in 30-day mortality, major complications and length of
hospital stay following thoracotomy. In terms of analgesic efficacy,
PVB was comparable to TEB, with a lower risk of failure of tech-
nique. PVB had a better minor complication profile with lower
incidence of hypotension, nausea and vomiting, pruritis and uri-
nary retention. Data were insufficient to compare PVB and TEB
in chronic pain and health costs.
Overall completeness and applicability of
evidence
The focus ofmany of the studieswas the analgesia provided byPVB
and TEB and minor complications in the peri-operative period.
There was limited evidence that suggests no difference in terms of
30-day mortality, major complications and length of stay between
the two techniques. The studies identified were insufficient to
compare PVB and TEB in terms of chronic pain and costs.
In a number of studies, different volumes and concentration of lo-
cal anaesthetic were used as loading dose and infusions for the two
blockades, which made it difficult to compare the results mean-
ingfully. These differences in study methodology mean that results
from our review should be interpreted with caution (Agreements
and disagreements with other studies or reviews).
Outcomes reported and compared in this review are only applica-
ble to adults undergoing elective open thoracotomy and shouldnot
be extrapolated to minimally-invasive surgery or cardiac surgery.
Quality of the evidence
We found the quality of evidence in terms of 30-day mortality
and major complications to be of low to very low quality due to
risks of bias, imprecision with low number of studies, and incon-
sistency. All 14 trials included in this review recruited relatively
small numbers of participants, with the smallest study covering 20
participants (Matthews 1989) and the largest recruiting 100 par-
ticipants (Richardson 1999). All included studies were described
as RCTs but a significant proportion of the studies did not give
any information on the method of randomization (eight out of
14 studies), and little effort was made to ensure allocation con-
cealment, or blinding of participants or outcome assessors. Whilst
the authors recognized that participant safety meant that it would
sometimes be necessary that staff caring for participants should
know towhich treatment group theywere allocated, the review au-
thors believe that assessors should be blinded to minimize report-
ing bias in measured outcomes. Only three studies (Casati 2006;
Grider 2012; Ibrahim 2009) attempted to blind participants, and
four studies blinded outcome assessors (Casati 2006; Grider 2012;
Ibrahim 2009; Pintaric 2011). No studies performed formal as-
sessment of effectiveness of allocation concealment and blinding.
We found the quality of evidence in terms of analgesic efficacy to
be moderate, due to the risks of bias (performance and detection
bias). Acute pain was the main focus of all the included studies
but the timing of VAS assessments varied (see Table 2). Although
VAS requires little training to administer and score, there is no
consensus on what represents a clinically meaningful difference,
with some researchers suggesting a minimum difference of 1.37
cm (Hawker 2011) or 2 cm to counter imprecision (DeLoach
1998). Unfortunately, the majority of studies did not report VAS
in enough detail to be included in themeta-analysis. In some stud-
ies, it was not clear whether VAS results were tested for normal-
ity. Kaiser 1998 also reported a categorical VAS of 0 to 4 as a
continuous variable (mean and SD). The duration of participant
follow-up was variable in studies, ranging from only three hours,
through 48 hours and up to five days. In studies of shorter dura-
tion, regional blockade was terminated and removed early, poten-
tially missing any associated benefits or differences between the
treatment groups. Supplementary analgesia and rescue analgesia
given to participants could provide a second measure of quality of
pain control, but this was not measured regularly in the included
studies. Two studies included participant satisfaction as an addi-
tional measure of successful pain relief (Casati 2006; De Cosmo
2002) but this could be affected by factors unrelated to pain man-
agement.
Potential biases in the review process
We strictly followed the review process recommended by
Cochrane. Two review authors independently assessed for inclu-
sion all the candidate studies we identified as a result of the search
strategy. Two review authors independently extracted the data
from the included studies using the agreed form. Two review au-
thors independently assessed risks of bias for each study using the
criteria outlined in the Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011). There should be no or minimal
biases in the review process.
Agreements and disagreements with other
studies or reviews
We identified three systematic reviews which addressed our re-
search question and compared only PVB and TEB (Baidya 2014;
Davies 2006; Norum 2010). Our findings that PVB and TEB
provided comparable pain relief concurred with two of the re-
views and themajority of published studies (Table 2; Baidya 2014;
Davies 2006).
Davies 2006 included 10 RCTs with 520 participants undergo-
ing thoracic surgery. They found no significant difference in VAS
scores (at rest) at four to eight, 24 and 48 hours, or in morphine
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consumption. Similarly, Baidya 2014 reported comparable anal-
gesia at four to eight, 24 and 48 hours, both at rest and on cough-
ing or during movement.
Our review found that at certain time points PVB appeared to
provide better analgesia, which was not the case in other reviews.
This may be due to the paucity of good-quality data and eligibility
of only a few studies for meta-analysis. We elected not to calculate
the mean and SD if only median and interquartile range were re-
ported, which was the case in Baidya 2014, due to the high level
of statistical assumptions. In contrast, Norum 2010 provided a
systematic narrative review, because of the heterogeneity and poor
quality of the studies that were available. The authors did not feel
that conclusions could be drawn from the available data on anal-
gesia or side-effect profile. They felt strongly that the method of
insertion (level of insertion too low) and regimen (no opiate or
adrenaline) employed with TEB in some published studies were
suboptimal, potentially introducing prejudice against TEB. They
further argued that measurement of pain at rest was not the best
indicator of pain control and pain during deep inspiration was a
more meaningful measure to distinguish effective from less effec-
tive analgesia. The authors also issued a warning about the appar-
ent lack of complications in the PVB group, citing their own ex-
perience that PVB complications, although infrequent, could still
be serious. Based on their findings, they could only recommend
the use of PVB if TEB was not technically feasible.
Kotze 2009 carried out a systematic review into the effectiveness
and safety of different techniques of paravertebral block for analge-
sia after thoracotomy.The authors found a trend towards improved
pain relief if PVB was established prior to skin incision. This po-
tential bias was worsened in some studies by the insertion and use
of TEB pre-operatively and during operation, thereby favouring
the effects of TEB.Their review concluded that continuous infu-
sion techniques were superior to bolus techniques for maintaining
analgesia, and higher doses of local anaesthetic produced better
analgesia and pulmonary function. The only reported complica-
tions from PVB were related to local anaesthetic toxicity (convul-
sions and cardiac arrhythmias) which resolved on termination of
local anaesthetic infusion. Our review identified similar variations
in PVB techniques, including timing and method of insertion, the
use of bolus and infusions and different concentrations of local
anaesthetic. In our review only one study (Richardson 1999) re-
ported one participant from the PVB group and three participant
from the TEB group who developed cardiac arrhythmias with un-
known cause.
Joshi 2008 provided a systematic review of all regional techniques
for post-thoracotomy analgesia and included other regional block-
ade (intrathecal, intercostal, intrapleural) and systemic analgesia.
The authors concluded that paravertebral block (local anaesthetic
only) and thoracic epidural (local anaesthetic and opiate) pro-
vided the best analgesia, and that either technique could be rec-
ommended.
Overall, complications were not reported regularly. Our review
found a more favourable side-effect profile of PVB compared with
TEB, which concurred with similar findings in Baidya 2014,
Davies 2006 and Joshi 2008. All three reviews agreed that the
incidence of major complications such as pneumonia, delirium
and minor complications such as urinary retention, hypotension,
pruritis and nausea and vomiting in participants, were reduced
with PVB. It is important to note that all of the studies included
in all of the reviews were designed to examine analgesia provided
by PVB and TEB, and that complications could be underreported
as a result.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
In participants undergoing thoracotomy, we found no difference
between PVB and TEB in 30-day mortality, major complications
and length of hospital stay. PVB provides comparable pain relief to
TEB in the immediate postoperative period, but data on chronic
pain are lacking. PVB also has a more favourable minor compli-
cation profile than TEB in thoracotomy.
Implications for research
Well-conducted future research comparing PVB and TEB in tho-
racotomy should include a randomized controlled trial design,
paying specific attention to randomization technique and method
of blinding to minimize potential bias. Studies should try to in-
corporate best practice (for example, timing, method of insertion,
concentration and volume of local anaesthetic), but at the same
time be pragmatic in design to reflect real-world variation in re-
gional anaesthesia technique. Areas identified from this review that
require further research include 30-day mortality, major compli-
cations, chronic pain and health costs.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bimston 1999
Methods Prospective, randomized trial
Participants 50 patients scheduled for open thoracotomy from2hospitals (EvanstonHospital, North-
western University Western Hospital, USA) between March 1996 and February 1997
Interventions TEB vs PVB 0.1% bupivacaine infusion. TEB inserted by anaesthetists (n=20), PVB
inserted by surgeons under direct vision (n=30)
Outcomes Pulmonary function by FEV and FVC; blood levels of bupivacaine and fentanyl at 6,
12, 24, 48 and 72 hrs, acute pain by VAS every 8 hrs until 96 hrs post-op
Funding sources Supported by Lung Cancer Study Fund of Evanston Northwestern Healthcare and
Evanston Faculty Practice Association, Anesthesiology Research and Development Fund
Conflict of interests None declared
Notes Detailed description of insertion of PVB catheter, no information on care of TEB partici-
pants. 2 groups of participants were cared for in separate locations according to treatment
received. TEB participants were under the care of anaesthetists and PVB participants
were under surgical team
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random units table
Allocation concealment (selection bias) Unclear risk No information available
Blinding of participants and personnel
(performance bias)
All outcomes
High risk 2 groups of participants were cared for in separate loca-
tions according to treatment received. TEB participants
were under the care of anaesthetists and PVB partici-
pants were under surgical team
Blinding of outcome assessment (detection
bias)
All outcomes
High risk 2 groups of participants were cared for in separate loca-
tions according to treatment received. TEB participants
were under the care of anaesthetists and PVB partici-
pants were under surgical team
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants completed study
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Bimston 1999 (Continued)
Selective reporting (reporting bias) Unclear risk Study was not registered on trial registration. It was not
possible to assess selective reporting
Other bias High risk Surgical procedures between 2 groups were different.
Higher proportion of TEB patients underwent more
extensive surgery, although authors argued that partici-
pants in PVB group underwent longer surgery and suf-
fered higher blood loss. No information on the care of
TEB group described (e.g. infusion rate, rescue analge-
sia)
Casati 2006
Methods Prospective, randomized controlled trial
Participants 42 patients scheduled for open thoracotomy from single centre (University of Parma,
Italy)
Interventions TEB (n=21) vs PVB (n=21) 0.2% ropivacaine infusion 5 - 10 ml/hr. PVB inserted by
3-injection technique and then inserted percutaneously by anaesthetists
Outcomes Acute pain scores (VAS) at rest and coughing, systolic BP, PaO /FiO , participant
satisfaction
Funding sources Not specified
Conflict of interests None declared
Notes Participant follow-up for 48 hours only
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated sequence
Allocation concealment (selection bias) Low risk Sealed envelope
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Same catheter and dressing used
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded observer
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Casati 2006 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants completed study
Selective reporting (reporting bias) Unclear risk Study was not registered on trial registration.
It was not possible to assess selective report-
ing
Other bias Low risk Follow-up was for 48 hours only
De Cosmo 2002
Methods Prospective randomized controlled trial
Participants 50 patients undergoing elective thoracotomy. Study was conducted at Universita Cat-
tolica del Sacro Cuore in Rome, Italy
Interventions TEB (n=25) inserted pre-operatively, 0.2% ropivacaine 5 ml loading dose, catheter used
during operation if required. For TEB, infusion of 0.2% ropivacaine with sufentanil 0.75
µg/ml at 5ml/hr. PVB (n=25) inserted at the endof procedure, 20ml 0.475% ropivacaine
given as loading dose, followed by 0.3% ropivacaine at 5 ml/hr postoperatively. Both
TEB and PVB infusions continued for 48 hours post-surgery
Outcomes VAS at rest and during movements at 1, 4, 8, 12, 24, 36 and 48 hours post-surgery.
Pulmonary function, complications, hospital stay and participant satisfaction
Funding sources Not specified
Conflict of interests None declared
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers
Allocation concealment (selection bias) Unclear risk No information available
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No method of blinding provided
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No method of blinding provided
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De Cosmo 2002 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk All participants completed study
Selective reporting (reporting bias) Unclear risk Study was not registered on trial registration.
It was not possible to assess selective reporting
Other bias Low risk Follow-up for 48 hours only
Grider 2012
Methods Prospective, 3-arm randomized double-blinded controlled trial
Participants 75 patients undergoing open thoracotomy from single site (University of Kentucky,
USA)
Interventions TEB with bupivacaine ± hydromorphine (n=50), PVB with bupivacaine only (n=25)
Outcomes Acute pain VAS at rest and during incentive spirometry twice daily until day 4 morning,
number of participants achieving spirometry volume > 2 L, basal infusion rates and use
of PCA in each group
Funding sources Not specified
Conflict of interests None declared
Notes All participants also received 3 intercostal nerve blocks before chest closure
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information available
Allocation concealment (selection bias) Unclear risk No information available
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Modality of analgesia that participant was
not randomized to was also in place but not
infused, to blind participant and personnel
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Modality of analgesia that participant was
not randomized to was also in place but not
infused, to blind observer
Incomplete outcome data (attrition bias)
All outcomes
Low risk 6 participants did not complete study, data
fromparticipants analysed using intention-
to-treat
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Grider 2012 (Continued)
Selective reporting (reporting bias) Unclear risk Study was not registered on trial registra-
tion. It was not possible to assess selective
reporting
Other bias Unclear risk Participants from both groups also received
3 intercostal nerve blocks before chest clo-
sure, which can impact on pain control
Gulbahar 2010
Methods Randomized controlled trial
Participants 50 patients enrolled. Study conducted in Turkey.
Interventions Thoracic epidural inserted prior to induction of GA, 5 ml 0.25% bupivacaine followed
by 0.1 ml/kg/hr infusion prior to closure (n=19)
PVB catheter placed after surgical procedure. 0.1 ml/kg/hr of 0.25% bupivacaine infu-
sion (n=25)
Catheters removed day 4
Outcomes Serum cortisol and glucose at 15 min, 4 hr, 12 hr, 24 hr, 48 hr postop
Number of participants who developed hypotension (> 20% decline in pre-op systolic/
diastolic pressure), urinary retention, sputum changes, auscultation disparities, radiolog-
ical changes, temp > 38, oxygenation saturation < 90%
Hospital stays
Morbidities, mortality during hospital stay
VAS scores, oxygen saturation, pulse, BP, spirometry (every 12 hrs), ABGs
Funding sources Not specified
Conflict of interests None declared
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information available
Allocation concealment (selection bias) Unclear risk No information available
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No method of blinding provided
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Gulbahar 2010 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No method of blinding provided
Incomplete outcome data (attrition bias)
All outcomes
High risk 6 participants with epidural. Data not included in anal-
yses
Selective reporting (reporting bias) Unclear risk Study was not registered on trial registration. It was not
possible to assess selective reporting
Other bias Unclear risk TEB catheter was used for analgesia throughout opera-
tion, PVB catheter inserted at the end only
Ibrahim 2009
Methods Randomized controlled trial
Participants 50 consecutive patients scheduled for lung resection with open thoracotomy. Study
conducted in Ain Shams University, Cairo
Interventions TEB (n=25) vs PVB (n=25) 0.375% ropivacaine at 0.1 ml/kg/hr
Outcomes Mean ABP, HR, CVP and SPO were recorded pre-operatively, immediately after in-
duction of general anaesthesia, (5, 10,15, 20 min) after the initial bolus of ropivacaine,
15 min after skin incision, every 15 min intra-operative, every hr for 6 hrs postop, and
then every 4 hrs. PaO /Fio , PaCO , FVC, FEV25 - 75, FEV /FVC, PEFR postop.
Duration of the operation and intra-operative fentanyl consumption. Also the total ropi-
vacaine consumption. The extent of the sensory blockade was tested by loss of pin-prick
sensation, serum cortisol and glucose concentrations before the start of the operation,
15 min after maximal surgical stimulus (rib retraction), 4 hours after maximal surgical
stimulus and 12 hours postoperatively. Incidence of N&V, hypotension, difficulties in
breathing, VAS score every 4 hrs for first 24 hrs postop
Funding sources Not specified
Conflict of interests None declared
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated numbers
Allocation concealment (selection bias) Low risk Sealed envelopes
35Paravertebral block versus thoracic epidural for patients undergoing thoracotomy (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ibrahim 2009 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Identical dressing applied to blind participant and per-
sonnel
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Identical dressing applied to blind observer
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants included
Selective reporting (reporting bias) Unclear risk Study was not registered on trial registration. It was not
possible to assess selective reporting
Other bias Low risk Standard general anaesthetic technique, same operating
surgeon
Kaiser 1998
Methods Prospective randomized trial
Participants 30 patients undergoing open thoracotomy. Study conducted in University Hospital,
Zurich
Interventions TEB placed before induction of GA, continuous infusion (4 to 6 mL/h) of 0.5% bupi-
vacaine during the operation; continuous infusion of 4 - 8 mL/h of 0.25% to 0.375%
bupivacaine with 2 mg/mL fentanyl postop (n=15). PVB placed before chest closure,
infusion of 20 mL bupivacaine 0.5% over 20 min. A continuous perfusion (0.1 mL/kg/
hr) with 0.5% bupivacaine with 0.05 U/mL of ornipressin (n=15)
Outcomes Acute pain 4 times/day using VAS. Daily consumption of opioid analgesics. Daily FVC,
FEV (best 3 consecutive measurements used). Serum levels of bupivacaine on day 1,
day 3 in participants in PVB group. Serious complications
Funding sources Not specified
Conflict of interests None declared
Notes Ornipressin is a vasoconstrictor
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information available
Allocation concealment (selection bias) Unclear risk No information available
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Kaiser 1998 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No method of blinding provided
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No method of blinding provided
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk All patients completed the study.
Selective reporting (reporting bias) Unclear risk Study was not registered on trial registration. It was not
possible to assess selective reporting
Other bias Unclear risk TEB placed preoperatively and used throughout the op-
eration. PVB inserted post operatively only
Kobayashi 2013
Methods Prospective randomized trial, non-inferiority design
Participants 70 open thoracotomy patients undergoing pulmonary resections in Aichi Cancer Centre
Hospital, Japan recruited between April and November 2008
Interventions TEB group had catheters inserted by anaesthetists prior to start of surgery but the catheter
was not used until end of surgery (n=35). PVB catheters were placed by surgeons under
direct vision at the end of the procedure (n=35). Both groups of participants received an
infusion of 0.2% ropivacaine with 10 mcg/ml of fentanyl for pain relief after operation.
Both groups of participants received an infusion of 0.2% ropivacaine with 10 mcg/ml
of fentanyl for pain relief after operation
Outcomes VAS scores and additional analgesic use were collected from both groups for 48 hours
after surgery
Funding sources Not specified
Conflict of interests None declared
Notes 2 participants from TEB group received PVB as treatment instead: 1 requested PVB as
treatment and TEB could not be inserted in the second participant. Data from both
participants were analysed in allocated TEB in compliance with intention-to-treat
Risk of bias
Bias Authors’ judgement Support for judgement
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Kobayashi 2013 (Continued)
Random sequence generation (selection
bias)
Unclear risk No information available
Allocation concealment (selection bias) Unclear risk No information available
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No method of blinding provided
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No method of blinding provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2 participants from TEB group received
PVB as treatment. Data included and anal-
ysed on intention-to-treat basis, according
to original group
Selective reporting (reporting bias) Unclear risk Study was not registered on trial registra-
tion. It was not possible to assess selective
reporting
Other bias Low risk Neither TEB nor PVB were used until the
end of surgery
Matthews 1989
Methods Randomized controlled trial
Participants 20 patients undergoing thoracotomy and pulmonary resection. Study conducted in UK
Interventions Epidural at T4/T5 after wound closure (n=10)
Paravertebral at T4/T5 (n=10)
10 ml 0.25% bupivacaine bolus given before extubation, 3 - 10 ml/hr
Outcomes Systolic BP and urine output hourly
Hypotension: decrease of BP > 30 mmHg
Urine retention if catheterization is required
VAS at 4, 12 and 24 hrs
Funding sources Not specified
Conflict of interests None declared
Notes
Risk of bias
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Matthews 1989 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information available.
Allocation concealment (selection bias) Unclear risk No information available.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No method of blinding provided
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No method of blinding provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data from1participant out of 10 inTEB group excluded
due to sustained hypotension
Selective reporting (reporting bias) Unclear risk Study was not registered on trial registration. It was not
possible to assess selective reporting
Other bias Unclear risk Neither interventionwas started until after the procedure
Messina 2009
Methods Prospective randomized controlled trial
Participants 24 patients undergoing thoracic surgery. Study conducted at Vita-Salute San Raffaele
University, Milan
Interventions Both PVB (n=12) andTEB (n=12) catheters were inserted percutaneously with landmark
technique before induction of general anaesthesia. Infusions were started at the end of
operation (0.25% levobupivacaine with fentanyl 1.6 µg/ml at 0.1 ml/kg/hr for PVB
group; 0.125% levobupivacaine and fentanyl 2 µg/ml at 0.08 ml/kg/hr in TEB group)
Outcomes Cumulative dose of morphine, VAS at rest and on movement, sedation level, spirometry
data (FVC, FEV ) and arterial blood gases for 72 hrs
Funding sources Not specified
Conflict of interests None declared
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Messina 2009 (Continued)
Random sequence generation (selection
bias)
Unclear risk No information available
Allocation concealment (selection bias) Unclear risk No information available
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No method of blinding provided
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No method of blinding provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants completed the study
Selective reporting (reporting bias) High risk VAS on movement, sedation scores and ar-
terial blood gases were collected but not re-
ported. Spirometry data were poorly reported
Other bias Unclear risk Institute has extensive experience in perform-
ing TEB. PVB was a new technique being ac-
quired after 30 cases
Murkerjee 2010
Methods Prospective, randomized single-blinded study
Participants 60 patients undergoing open thoracotomy in the Institute of Postgraduate Medical
Education and Research, Kolkata, recruited between February 2007 and August 2008
Interventions TEB vs PVB; both blocks used 30 mins prior to the end of surgery. 7.5 ml for TEB
and 15 ml for thoracic PVB of 0.25% bupivacaine, along with 1 ml of fentanyl for
postoperative analgesia
Outcomes Pulse rate (P), SBP, DBP and MAP, incidence of adverse events (dural puncture, failure
of placement)
Funding sources Not specified
Conflict of interests None declared
Notes 1 TEB, 3 PVB vascular puncture, block successfully replaced after
Risk of bias
Bias Authors’ judgement Support for judgement
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Murkerjee 2010 (Continued)
Random sequence generation (selection
bias)
Unclear risk No information available
Allocation concealment (selection bias) Unclear risk No information available
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No method of blinding provided
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No method of blinding provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants completed the study
Selective reporting (reporting bias) Unclear risk Study was not registered on trial registra-
tion. It was not possible to assess selective
reporting
Other bias Unclear risk Short study, terminated when patients re-
quested rescue analgesia, severity of pain
not recorded
Perttunen 1995
Methods Prospective randomized study
Participants 45 patients undergoing open thoracotomy at Helsinki University Central Hospital, Fin-
land
Interventions Intrathoracic 4 intercostal nerve blocks by surgeons (16 ml 0.5% bupivacaine), TEB
were inserted pre-op (n=15), PVB (n=15)at chest closure by surgeon (0.25% bupivacaine
8 - 12 mls at 4/6/8ml/hr infusion rate according to height of participants)
Outcomes Acute pain by VAS and VRS at rest and coughing hourly (first 6 hrs), 20, 24, 30, 48 hr.
Spread of sensory block by pin prick. Incidence of adverse events (drowsiness, confusion,
N&V, itchiness, abdominal pain, dizziness, hallucination, difficulties in breathing or
allergic reactions), performance status. SpO , Hb, PCV and urine output (2 days),
ABG (every 30 min until 6 hrs then 24, 48 hrs), serum bupivacaine concentration pre-
operatively, 10 min, 30 min, 60 min, 2, 4, 6 and 24 hrs
Funding sources Authors supported by Urho Kankkanen and Academy of Finland
Conflict of interests None declared
Notes 3 groups, only data from TEB and PVB group included in this review
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Perttunen 1995 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information available
Allocation concealment (selection bias) Unclear risk No information available
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No method of blinding provided
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No method of blinding provided
Incomplete outcome data (attrition bias)
All outcomes
High risk < 15% excluded, only 45 participants completed the
study
Selective reporting (reporting bias) Unclear risk Study was not registered on trial registration. It was not
possible to assess selective reporting
Other bias Low risk VAS scores, morphine consumption and sensory block
assessed
Pintaric 2011
Methods Prospective randomized study
Participants 32patients undergoing open thoracotomy atUniversityMedical Centre Ljubljana, Slove-
nia
Interventions Epidural analgesia (0.25% levobupivacaine and 30 µg/kg morphine, n=16) or paraver-
tebral block (0.5% levobupivacaine and 30 µg/kg morphine, n=16)
Outcomes Oxygen delivery, stroke volume and SVR indices, HR, and MAP measurements before
administration of local anaesthetic, after induction of GA, institution of 1-lung ventila-
tion, first skin incision, retractor placement, lung-inflation manoeuvre, and at last skin
suture. Primary end point:volume of the colloid infusion necessary to maintain oxygen
delivery index of 500 mL/min per squared meter or higher. Pain, rescue-analgesia con-
sumption, arterial pressure, and HR were recorded at 6, 24, and 48 hrs after surgery
Funding sources Not specified
Conflict of interests None declared
Notes One participant from PVB excluded due to insufficient block
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Pintaric 2011 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated sequence
Allocation concealment (selection bias) Low risk Sealed envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Identical dressing used to disguise group allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Identical dressing used to disguise group allocation, sin-
gle-blinded physiotherapist as observer
Incomplete outcome data (attrition bias)
All outcomes
Low risk One participant from PVB excluded due to insufficient
block
Selective reporting (reporting bias) Unclear risk Study was not registered on trial registration. It was not
possible to assess selective reporting
Other bias Low risk Both TEB and PVB inserted preoperatively and used
Richardson 1999
Methods Prospective randomized trial
Participants 100 patients undergoing planned thoracotomy at Bradford Royal Infirmary, Bradford
Interventions TEB (0.5% bupivacaine 10 - 15 ml bolus, n=54), PVB by surgeons (0.25% bupivacaine
20 ml, infusion rate at 0.1 ml/kg/hr, n=46)
Outcomes 4-hourly VAS scores, PCA morphine requirements, sedation score, N&V, SpO , 12-
hourly spirometry, serum glucose and cortisol at 15 min, 4, 12, 24 hrs. Incidence of
hypotension, urinary retention, postoperative pulmonary complications. N of patients
complaining of pain at follow-up clinic
Funding sources Laboratory analysis supported by Lungs for Life
Conflict of interests None declared
Notes TEB inserted at T7 - 10 pre-operatively, lower levels than levels of thoracotomy (T5/6
or T7/8)
Risk of bias
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Richardson 1999 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Sequential allocation of computer-generated random
numbers
Allocation concealment (selection bias) Unclear risk No information available
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No method of blinding provided
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No method of blinding provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk < 15% or fewer
Selective reporting (reporting bias) Unclear risk Study was not registered on trial registration. It was not
possible to assess selective reporting
Other bias Unclear risk None identified
ABGs: arterial blood gases
ABP: arterial blood pressure
BP: blood pressure
CVP: central venous pressure
DBP: diastolic blood pressure
FEV : forced expiratory volume over 1 second
FVC: Forced vital capacity
GA: General anaesthesia
mmHg: millimetres of mercury
HR: heart rate
Hrs: hours
Kg: kilogram
MAP: mean arterial pressure
min: minutes
ml: millilitres
mm: millimetre
N&V: nausea and vomiting
PaO : partial pressure of oxygen in arterial blood
PCA: patient-controlled analgesia
PCV: packed cell volume
PEFR: peak expiratory flow rate
PVB: paravertebral blockade
RCT: randomized controlled trial
SBP: systolic blood pressure
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SPO : Oxygenation saturation
T4: fourth thoracic vertebra
TEB: thoracic epidural
U: unit
µg: microgram
VAS: visual analogue scale
VRS: verbal rating scale
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Elsayed 2012 Retrospective analysis
Kanazi 2012 Subpleural analgesia technique did not constitute a paravertebral block
Kozar 2011 Chronic pain measured at 3 months
Characteristics of studies awaiting assessment [ordered by study ID]
Raveglia 2014
Methods Prospective, randomized study
Participants 71 patients undergoing thoracotomy
Interventions Thoracic epidural, paravertebral blockade
Outcomes VAS for pain control, FEV and saturation for respiratory function, blood cortisol for response to pain
Notes Paravertebral blockade considered as effective as thoracic epidural
Wedad 2004
Methods Unknown
Participants Unknown
Interventions Thoracic epidural, thoracic paravertebral and interpleural analgesia with wound infiltration
Outcomes Acute pain using VAS day 1 & 2, pethidine consumption
Notes Unable to obtain a copy of this study
FEV : Forced expiratory volume over 1 second
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VAS: Visual analogue scale
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D A T A A N D A N A L Y S E S
Comparison 1. 30-day mortality
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 30-day mortality 2 125 Risk Ratio (M-H, Fixed, 95% CI) 1.28 [0.39, 4.24]
Comparison 2. Major complications
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Cardiovascular complications 2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Hypotension requiring
inotropic support
1 19 Risk Ratio (M-H, Random, 95% CI) 0.30 [0.01, 6.62]
1.2 Arrhythmia 1 95 Risk Ratio (M-H, Random, 95% CI) 0.36 [0.04, 3.29]
1.3 Myocardial infarction 1 95 Risk Ratio (M-H, Random, 95% CI) 3.19 [0.13, 76.42]
2 Respiratory complications 5 280 Risk Ratio (M-H, Random, 95% CI) 0.62 [0.26, 1.52]
2.1 Postoperative ventilatory
support
1 75 Risk Ratio (M-H, Random, 95% CI) 0.39 [0.02, 7.88]
2.2 Acute carbon dioxide
retention
1 30 Risk Ratio (M-H, Random, 95% CI) 1.2 [0.47, 3.09]
2.3 Pneumonia 3 175 Risk Ratio (M-H, Random, 95% CI) 0.38 [0.10, 1.45]
3 Neurological complication
(Delirium)
2 125 Risk Ratio (M-H, Fixed, 95% CI) 0.31 [0.09, 1.00]
4 Unexpected ITU admission 2 139 Risk Ratio (M-H, Fixed, 95% CI) 0.63 [0.19, 2.07]
Comparison 3. Acute pain
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 VAS scores 2 to 6 hours 6 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 VAS at rest 6 239 Std. Mean Difference (IV, Random, 95% CI) 0.32 [-0.30, 0.94]
1.2 VAS on coughing/after
physiotherapy
3 126 Std. Mean Difference (IV, Random, 95% CI) 0.41 [-0.20, 1.03]
2 VAS scores at 24 hours 6 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 VAS at rest 6 239 Std. Mean Difference (IV, Random, 95% CI) 0.16 [-0.17, 0.48]
2.2 VAS on coughing/after
physiology
3 126 Std. Mean Difference (IV, Random, 95% CI) -0.23 [-0.58, 0.12]
3 VAS scores at 48 hours 5 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
3.1 VAS at rest 5 220 Std. Mean Difference (IV, Random, 95% CI) -0.12 [-0.46, 0.22]
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3.2 VAS on coughing/after
physiotherapy
3 126 Std. Mean Difference (IV, Random, 95% CI) 0.25 [-0.16, 0.66]
4 Failure of technique 4 199 Risk Ratio (M-H, Fixed, 95% CI) 0.27 [0.09, 0.86]
Comparison 4. Minor complications
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Hypotension 8 445 Risk Ratio (M-H, Fixed, 95% CI) 0.16 [0.07, 0.38]
2 Nausea and vomiting 6 345 Risk Ratio (M-H, Fixed, 95% CI) 0.48 [0.30, 0.75]
3 Excessive sedation 3 175 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.57, 1.24]
4 Pruritis 5 249 Risk Ratio (M-H, Fixed, 95% CI) 0.29 [0.14, 0.59]
5 Urinary retention 5 258 Risk Ratio (M-H, Fixed, 95% CI) 0.22 [0.11, 0.46]
Comparison 5. Hospital stay
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Duration of hospital stay 3 124 Mean Difference (IV, Fixed, 95% CI) -0.41 [-1.54, 0.72]
Analysis 1.1. Comparison 1 30-day mortality, Outcome 1 30-day mortality.
Review: Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Comparison: 1 30-day mortality
Outcome: 1 30-day mortality
Study or subgroup PVB TEB Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Kaiser 1998 0/15 1/15 34.1 % 0.33 [ 0.01, 7.58 ]
Richardson 1999 5/46 3/49 65.9 % 1.78 [ 0.45, 7.01 ]
Total (95% CI) 61 64 100.0 % 1.28 [ 0.39, 4.24 ]
Total events: 5 (PVB), 4 (TEB)
Heterogeneity: Chi2 = 0.93, df = 1 (P = 0.34); I2 =0.0%
Test for overall effect: Z = 0.41 (P = 0.68)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours PVB Favours TEB
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Analysis 2.1. Comparison 2 Major complications, Outcome 1 Cardiovascular complications.
Review: Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Comparison: 2 Major complications
Outcome: 1 Cardiovascular complications
Study or subgroup PVB TEB Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Hypotension requiring inotropic support
Matthews 1989 0/10 1/9 100.0 % 0.30 [ 0.01, 6.62 ]
Subtotal (95% CI) 10 9 100.0 % 0.30 [ 0.01, 6.62 ]
Total events: 0 (PVB), 1 (TEB)
Heterogeneity: not applicable
Test for overall effect: Z = 0.76 (P = 0.45)
2 Arrhythmia
Richardson 1999 1/46 3/49 100.0 % 0.36 [ 0.04, 3.29 ]
Subtotal (95% CI) 46 49 100.0 % 0.36 [ 0.04, 3.29 ]
Total events: 1 (PVB), 3 (TEB)
Heterogeneity: not applicable
Test for overall effect: Z = 0.91 (P = 0.36)
3 Myocardial infarction
Richardson 1999 1/46 0/49 100.0 % 3.19 [ 0.13, 76.42 ]
Subtotal (95% CI) 46 49 100.0 % 3.19 [ 0.13, 76.42 ]
Total events: 1 (PVB), 0 (TEB)
Heterogeneity: not applicable
Test for overall effect: Z = 0.72 (P = 0.47)
0.01 0.1 1 10 100
Favours TEB Favours PVB
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Analysis 2.2. Comparison 2 Major complications, Outcome 2 Respiratory complications.
Review: Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Comparison: 2 Major complications
Outcome: 2 Respiratory complications
Study or subgroup PVB TEB Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Postoperative ventilatory support
Grider 2012 0/25 2/50 8.0 % 0.39 [ 0.02, 7.88 ]
Subtotal (95% CI) 25 50 8.0 % 0.39 [ 0.02, 7.88 ]
Total events: 0 (PVB), 2 (TEB)
Heterogeneity: not applicable
Test for overall effect: Z = 0.61 (P = 0.54)
2 Acute carbon dioxide retention
Perttunen 1995 6/15 5/15 41.4 % 1.20 [ 0.47, 3.09 ]
Subtotal (95% CI) 15 15 41.4 % 1.20 [ 0.47, 3.09 ]
Total events: 6 (PVB), 5 (TEB)
Heterogeneity: not applicable
Test for overall effect: Z = 0.38 (P = 0.71)
3 Pneumonia
Bimston 1999 4/30 3/20 27.1 % 0.89 [ 0.22, 3.55 ]
Kaiser 1998 0/15 2/15 8.2 % 0.20 [ 0.01, 3.85 ]
Richardson 1999 1/46 8/49 15.4 % 0.13 [ 0.02, 1.02 ]
Subtotal (95% CI) 91 84 50.6 % 0.38 [ 0.10, 1.45 ]
Total events: 5 (PVB), 13 (TEB)
Heterogeneity: Tau2 = 0.42; Chi2 = 2.77, df = 2 (P = 0.25); I2 =28%
Test for overall effect: Z = 1.42 (P = 0.16)
Total (95% CI) 131 149 100.0 % 0.62 [ 0.26, 1.52 ]
Total events: 11 (PVB), 20 (TEB)
Heterogeneity: Tau2 = 0.27; Chi2 = 5.38, df = 4 (P = 0.25); I2 =26%
Test for overall effect: Z = 1.04 (P = 0.30)
Test for subgroup differences: Chi2 = 2.11, df = 2 (P = 0.35), I2 =5%
0.01 0.1 1 10 100
Favours TEB Favours PVB
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Analysis 2.3. Comparison 2 Major complications, Outcome 3 Neurological complication (Delirium).
Review: Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Comparison: 2 Major complications
Outcome: 3 Neurological complication (Delirium)
Study or subgroup PVB TEB Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Perttunen 1995 2/15 7/15 70.7 % 0.29 [ 0.07, 1.16 ]
Richardson 1999 1/46 3/49 29.3 % 0.36 [ 0.04, 3.29 ]
Total (95% CI) 61 64 100.0 % 0.31 [ 0.09, 1.00 ]
Total events: 3 (PVB), 10 (TEB)
Heterogeneity: Chi2 = 0.03, df = 1 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 1.96 (P = 0.050)
Test for subgroup differences: Not applicable
0.05 0.2 1 5 20
Favours PVB Favours TEB
Analysis 2.4. Comparison 2 Major complications, Outcome 4 Unexpected ITU admission.
Review: Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Comparison: 2 Major complications
Outcome: 4 Unexpected ITU admission
Study or subgroup PVB TEB Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gulbahar 2010 1/25 3/19 54.0 % 0.25 [ 0.03, 2.25 ]
Richardson 1999 3/46 3/49 46.0 % 1.07 [ 0.23, 5.01 ]
Total (95% CI) 71 68 100.0 % 0.63 [ 0.19, 2.07 ]
Total events: 4 (PVB), 6 (TEB)
Heterogeneity: Chi2 = 1.11, df = 1 (P = 0.29); I2 =10%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours PVB Favours TEB
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Analysis 3.1. Comparison 3 Acute pain, Outcome 1 VAS scores 2 to 6 hours.
Review: Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Comparison: 3 Acute pain
Outcome: 1 VAS scores 2 to 6 hours
Study or subgroup PVB TEB
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 VAS at rest
De Cosmo 2002 25 2.6 (0.7) 25 1 (1) 16.9 % 1.82 [ 1.16, 2.49 ]
Grider 2012 23 3.3 (0.4) 22 3.4 (0.4) 17.7 % -0.25 [ -0.83, 0.34 ]
Kobayashi 2013 35 2.6 (2) 35 2.4 (1.9) 18.8 % 0.10 [ -0.37, 0.57 ]
Matthews 1989 10 1.3 (1.1) 9 1.3 (1.2) 14.6 % 0.0 [ -0.90, 0.90 ]
Messina 2009 12 3 (2.7) 12 2 (2.5) 15.5 % 0.37 [ -0.44, 1.18 ]
Pintaric 2011 16 1.8 (1.8) 15 2.1 (2.3) 16.5 % -0.14 [ -0.85, 0.56 ]
Subtotal (95% CI) 121 118 100.0 % 0.32 [ -0.30, 0.94 ]
Heterogeneity: Tau2 = 0.47; Chi2 = 25.97, df = 5 (P = 0.00009); I2 =81%
Test for overall effect: Z = 1.01 (P = 0.31)
2 VAS on coughing/after physiotherapy
De Cosmo 2002 25 3.7 (0.8) 25 2.2 (2.1) 34.9 % 0.93 [ 0.34, 1.52 ]
Grider 2012 23 3.6 (0.5) 22 3.4 (0.4) 34.6 % 0.43 [ -0.16, 1.02 ]
Pintaric 2011 16 2.4 (1.5) 15 2.8 (2.4) 30.5 % -0.20 [ -0.90, 0.51 ]
Subtotal (95% CI) 64 62 100.0 % 0.41 [ -0.20, 1.03 ]
Heterogeneity: Tau2 = 0.19; Chi2 = 5.79, df = 2 (P = 0.06); I2 =65%
Test for overall effect: Z = 1.32 (P = 0.19)
Test for subgroup differences: Chi2 = 0.05, df = 1 (P = 0.83), I2 =0.0%
-1 -0.5 0 0.5 1
Favours PVB Favours TEB
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Analysis 3.2. Comparison 3 Acute pain, Outcome 2 VAS scores at 24 hours.
Review: Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Comparison: 3 Acute pain
Outcome: 2 VAS scores at 24 hours
Study or subgroup PVB TEB
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 VAS at rest
De Cosmo 2002 25 2.4 (0.7) 25 1.8 (2) 20.1 % 0.39 [ -0.17, 0.95 ]
Grider 2012 23 3.4 (0.6) 22 3 (0.4) 18.1 % 0.77 [ 0.16, 1.37 ]
Kobayashi 2013 35 1.1 (1) 35 1.2 (1.2) 24.4 % -0.09 [ -0.56, 0.38 ]
Matthews 1989 10 1.4 (1.5) 9 1.3 (0.9) 10.3 % 0.08 [ -0.82, 0.98 ]
Messina 2009 12 1 (1.4) 12 1 (2.1) 12.4 % 0.0 [ -0.80, 0.80 ]
Pintaric 2011 16 0.8 (1.3) 15 1.3 (1.7) 14.7 % -0.32 [ -1.03, 0.39 ]
Subtotal (95% CI) 121 118 100.0 % 0.16 [ -0.17, 0.48 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 7.56, df = 5 (P = 0.18); I2 =34%
Test for overall effect: Z = 0.95 (P = 0.34)
2 VAS on coughing/after physiology
De Cosmo 2002 25 3.6 (1) 25 3.7 (2.5) 40.2 % -0.05 [ -0.61, 0.50 ]
Grider 2012 23 3.6 (0.5) 22 3.7 (0.6) 36.1 % -0.18 [ -0.76, 0.41 ]
Pintaric 2011 16 1.4 (1.5) 15 2.6 (2.3) 23.7 % -0.61 [ -1.33, 0.12 ]
Subtotal (95% CI) 64 62 100.0 % -0.23 [ -0.58, 0.12 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.47, df = 2 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 1.27 (P = 0.20)
Test for subgroup differences: Chi2 = 2.49, df = 1 (P = 0.11), I2 =60%
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Analysis 3.3. Comparison 3 Acute pain, Outcome 3 VAS scores at 48 hours.
Review: Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Comparison: 3 Acute pain
Outcome: 3 VAS scores at 48 hours
Study or subgroup PVB TEB
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 VAS at rest
De Cosmo 2002 25 2.2 (2.6) 25 1.8 (1.1) 22.5 % 0.20 [ -0.36, 0.75 ]
Grider 2012 23 3.6 (0.3) 22 3.5 (0.6) 21.0 % 0.21 [ -0.38, 0.79 ]
Kobayashi 2013 35 0.8 (0.8) 35 1.3 (1) 26.8 % -0.55 [ -1.02, -0.07 ]
Messina 2009 12 2 (3.2) 12 2 (2) 13.5 % 0.0 [ -0.80, 0.80 ]
Pintaric 2011 16 0.9 (1.7) 15 1.6 (1.9) 16.1 % -0.38 [ -1.09, 0.33 ]
Subtotal (95% CI) 111 109 100.0 % -0.12 [ -0.46, 0.22 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 6.10, df = 4 (P = 0.19); I2 =34%
Test for overall effect: Z = 0.70 (P = 0.49)
2 VAS on coughing/after physiotherapy
De Cosmo 2002 25 3.4 (0.9) 25 3 (1.4) 38.3 % 0.33 [ -0.22, 0.89 ]
Grider 2012 23 3.9 (0.6) 22 3.6 (0.5) 34.9 % 0.53 [ -0.06, 1.13 ]
Pintaric 2011 16 1.7 (1.7) 15 2.1 (1.8) 26.8 % -0.22 [ -0.93, 0.48 ]
Subtotal (95% CI) 64 62 100.0 % 0.25 [ -0.16, 0.66 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 2.66, df = 2 (P = 0.26); I2 =25%
Test for overall effect: Z = 1.22 (P = 0.22)
Test for subgroup differences: Chi2 = 1.91, df = 1 (P = 0.17), I2 =48%
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Analysis 3.4. Comparison 3 Acute pain, Outcome 4 Failure of technique.
Review: Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Comparison: 3 Acute pain
Outcome: 4 Failure of technique
Study or subgroup PVB TEB Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gulbahar 2010 0/25 2/19 22.3 % 0.15 [ 0.01, 3.03 ]
Kaiser 1998 2/15 2/15 15.8 % 1.00 [ 0.16, 6.20 ]
Perttunen 1995 0/15 2/15 19.8 % 0.20 [ 0.01, 3.85 ]
Richardson 1999 0/46 5/49 42.1 % 0.10 [ 0.01, 1.70 ]
Total (95% CI) 101 98 100.0 % 0.27 [ 0.09, 0.86 ]
Total events: 2 (PVB), 11 (TEB)
Heterogeneity: Chi2 = 2.63, df = 3 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 2.22 (P = 0.027)
Test for subgroup differences: Not applicable
0.005 0.1 1 10 200
Favours PVB Favours TEB
55Paravertebral block versus thoracic epidural for patients undergoing thoracotomy (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.1. Comparison 4 Minor complications, Outcome 1 Hypotension.
Review: Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Comparison: 4 Minor complications
Outcome: 1 Hypotension
Study or subgroup PVB TEB Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Bimston 1999 1/30 1/20 3.3 % 0.67 [ 0.04, 10.05 ]
Casati 2006 0/21 4/21 12.3 % 0.11 [ 0.01, 1.94 ]
Grider 2012 0/25 3/50 6.5 % 0.28 [ 0.02, 5.22 ]
Gulbahar 2010 0/25 2/19 7.7 % 0.15 [ 0.01, 3.03 ]
Ibrahim 2009 0/25 6/25 17.8 % 0.08 [ 0.00, 1.30 ]
Kobayashi 2013 2/35 5/35 13.7 % 0.40 [ 0.08, 1.93 ]
Matthews 1989 0/10 6/9 18.7 % 0.07 [ 0.00, 1.09 ]
Richardson 1999 0/46 7/49 19.9 % 0.07 [ 0.00, 1.21 ]
Total (95% CI) 217 228 100.0 % 0.16 [ 0.07, 0.38 ]
Total events: 3 (PVB), 34 (TEB)
Heterogeneity: Chi2 = 3.48, df = 7 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 4.21 (P = 0.000026)
Test for subgroup differences: Not applicable
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Analysis 4.2. Comparison 4 Minor complications, Outcome 2 Nausea and vomiting.
Review: Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Comparison: 4 Minor complications
Outcome: 2 Nausea and vomiting
Study or subgroup PVB TEB Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Bimston 1999 8/30 6/20 15.6 % 0.89 [ 0.36, 2.17 ]
De Cosmo 2002 0/25 2/25 5.4 % 0.20 [ 0.01, 3.97 ]
Ibrahim 2009 6/25 10/25 21.7 % 0.60 [ 0.26, 1.40 ]
Kobayashi 2013 3/35 8/35 17.3 % 0.38 [ 0.11, 1.30 ]
Perttunen 1995 2/15 2/15 4.3 % 1.00 [ 0.16, 6.20 ]
Richardson 1999 4/46 17/49 35.7 % 0.25 [ 0.09, 0.69 ]
Total (95% CI) 176 169 100.0 % 0.48 [ 0.30, 0.75 ]
Total events: 23 (PVB), 45 (TEB)
Heterogeneity: Chi2 = 4.80, df = 5 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 3.18 (P = 0.0015)
Test for subgroup differences: Not applicable
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Analysis 4.3. Comparison 4 Minor complications, Outcome 3 Excessive sedation.
Review: Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Comparison: 4 Minor complications
Outcome: 3 Excessive sedation
Study or subgroup PVB TEB Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Bimston 1999 6/30 6/20 34.0 % 0.67 [ 0.25, 1.78 ]
Perttunen 1995 12/15 13/15 61.4 % 0.92 [ 0.67, 1.27 ]
Richardson 1999 1/46 1/49 4.6 % 1.07 [ 0.07, 16.54 ]
Total (95% CI) 91 84 100.0 % 0.84 [ 0.57, 1.24 ]
Total events: 19 (PVB), 20 (TEB)
Heterogeneity: Chi2 = 0.56, df = 2 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 0.87 (P = 0.39)
Test for subgroup differences: Not applicable
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Analysis 4.4. Comparison 4 Minor complications, Outcome 4 Pruritis.
Review: Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Comparison: 4 Minor complications
Outcome: 4 Pruritis
Study or subgroup PVB TEB Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Bimston 1999 5/30 5/20 20.3 % 0.67 [ 0.22, 2.01 ]
De Cosmo 2002 0/25 2/25 8.5 % 0.20 [ 0.01, 3.97 ]
Grider 2012 0/25 6/50 14.9 % 0.15 [ 0.01, 2.58 ]
Gulbahar 2010 0/25 8/19 32.6 % 0.05 [ 0.00, 0.74 ]
Perttunen 1995 3/15 7/15 23.7 % 0.43 [ 0.14, 1.35 ]
Total (95% CI) 120 129 100.0 % 0.29 [ 0.14, 0.59 ]
Total events: 8 (PVB), 28 (TEB)
Heterogeneity: Chi2 = 4.57, df = 4 (P = 0.33); I2 =13%
Test for overall effect: Z = 3.46 (P = 0.00055)
Test for subgroup differences: Not applicable
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Analysis 4.5. Comparison 4 Minor complications, Outcome 5 Urinary retention.
Review: Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Comparison: 4 Minor complications
Outcome: 5 Urinary retention
Study or subgroup PVB TEB Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Bimston 1999 0/30 6/20 23.3 % 0.05 [ 0.00, 0.88 ]
De Cosmo 2002 0/25 3/25 10.5 % 0.14 [ 0.01, 2.63 ]
Gulbahar 2010 0/25 4/19 15.3 % 0.09 [ 0.00, 1.50 ]
Matthews 1989 1/10 6/9 19.0 % 0.15 [ 0.02, 1.02 ]
Richardson 1999 5/46 11/49 32.0 % 0.48 [ 0.18, 1.29 ]
Total (95% CI) 136 122 100.0 % 0.22 [ 0.11, 0.46 ]
Total events: 6 (PVB), 30 (TEB)
Heterogeneity: Chi2 = 4.11, df = 4 (P = 0.39); I2 =3%
Test for overall effect: Z = 4.02 (P = 0.000058)
Test for subgroup differences: Not applicable
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Analysis 5.1. Comparison 5 Hospital stay, Outcome 1 Duration of hospital stay.
Review: Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
Comparison: 5 Hospital stay
Outcome: 1 Duration of hospital stay
Study or subgroup PVB TEB
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
De Cosmo 2002 25 7.4 (3) 25 7.7 (4) 33.2 % -0.30 [ -2.26, 1.66 ]
Gulbahar 2010 25 14.6 (5.57) 19 15.74 (5.02) 12.9 % -1.14 [ -4.28, 2.00 ]
Kaiser 1998 15 15.2 (2.1) 15 15.5 (2.2) 53.9 % -0.30 [ -1.84, 1.24 ]
Total (95% CI) 65 59 100.0 % -0.41 [ -1.54, 0.72 ]
Heterogeneity: Chi2 = 0.24, df = 2 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 0.71 (P = 0.48)
Test for subgroup differences: Not applicable
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A D D I T I O N A L T A B L E S
Table 1. Technical aspects of PVB and TEB catheters
PVB TEB
STUDY METHOD OF
INSERTION
METHOD OF
USE
POSTOPER-
ATIVE MEDI-
CATION
METHOD OF
INSERTION
METHOD OF
USE
POSTOPER-
ATIVE MEDI-
CATION
Bimston 1999 Inserted un-
der direct vision
by surgeon
18 ml 0.5%
bupivacaine bo-
lus followed by
infusion of 0.1%
bupivacainewith
10 µg/ml fen-
tanyl, 10 - 15ml/
hr
infusion of 0.1%
bupivacainewith
10 µg/ml fen-
tanyl, 10 - 15ml/
min
Percuta-
neously by land-
mark technique
before induction
of GA
Uncertain
whether catheter
was used during
operation
Infusion of 0.1%
bupivacainewith
10 µg/ml fen-
tanyl, 10 - 15ml/
hr
Casati 2006I Percuta-
neously by land-
mark technique
before induction
of GA
Pre-op In-
jections by land-
mark technique
before induction
of GA
15 ml of 0.75%
infusion of 0.2%
ropivacaine at 5 -
10ml/hr
Percuta-
neously by land-
mark technique
before induction
of GA
5 ml bolus of 0.
75% ropivacaine
infusion of 0.2%
ropivacaine at 5 -
10 ml/hr
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Table 1. Technical aspects of PVB and TEB catheters (Continued)
ropivacaine
DeCosmo2002 Inserted un-
der direct vision
by surgeons
Used at the end
of operation only
20 ml of 0.475%
ropivacaine
as loading dose,
infusion of 0.
3% ropivacaine
at 5 ml/hr post-
surgery
Percuta-
neously by land-
mark technique
before induction
of GA
5 ml bolus of 0.
2%
ropivacaine and
sufentanil 10 µg
given as bolus.
Catheter used
during operation
if required
Infusion of 0.2%
ropivacaine with
0.75 µg/ml of
sufentanil at 5
ml/hr
Grider 2012 Inserted un-
der direct vision
by surgeon
Used at the end
of the operation
only
0.25%
bupivacaine at 8
ml/hr
Percuta-
neously by land-
mark technique
before induction
of GA
Used at the end
of operation
0.25% bupi-
vacaine 2 ml/hr
with 1 ml every
10 min PCEA
with or without
hydromorphine
Gulbahar 2010 Inserted un-
der direct vision
by surgeon
Used at the end
of operation only
0.25% bupi-
vacaine infusion
at 0.0 ml/kg/hr
PCEA
Percuta-
neously by land-
mark technique
before induction
of GA
Used at the end
of operation
5 ml of 0.25%
bupiva-
caine bolus, fol-
lowed by 0.0 ml/
kg/hr PCEA
Ibrahim 2009 Percuta-
neously by land-
mark technique
before induction
of GA
15 - 20 ml 0.5%
ropivacaine bo-
lus followed by
0.375% ropiva-
caine 0.1 ml/kg/
hr infusion
0.375% ropiva-
caine 0.1 ml/kg/
hr infusion
Percuta-
neously by land-
mark technique
before induction
of GA
5 - 8 ml of 0.5%
ropivacaine bo-
lus followed by
0.375% ropiva-
caine 0.1 ml/kg.
hr infusion
0.375% ropiva-
caine 0.1 ml/kg/
hr infusion
Kaiser 1998 Inserted un-
der direct vision
by surgeon
Used at the end
of operation only
20
ml 0.5% bupiva-
caine bolus fol-
lowed by 0.1 ml/
kg/hr of 0.5%
bupivacaine
Percuta-
neously by land-
mark technique
before induction
of GA
0.5% bupiva-
caine at 4 - 6 ml/
hr infusion dur-
ing operation
4 - 8 ml/hr of
0.25 - 0.375%
bupivacainewith
2µg/ml fentanyl
Kobayashi
2013
Inserted un-
der direct vision
by surgeon
Used at the end
of operation only
10 ml
0.375% ropiva-
caine bolus fol-
lowed by 0.2%
ropivacaine with
fentanyl 9.5 µg/
ml at 5 ml/hr in-
fusion
Percuta-
neously by land-
mark technique
before induction
of GA
Used at the end
of operation
5
ml 0.2% ropiva-
caine bolus fol-
lowed by 0.2%
ropivacaine with
fentanyl 9.5 µg/
ml at 5 ml/hr in-
fusion
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Table 1. Technical aspects of PVB and TEB catheters (Continued)
Matthews 1989 Percuta-
neously by land-
mark at the end
of procedure
Used at the end
of operation only
10 ml 0.25%
bupivacaine bo-
lus followed by
infusion at 5 ml/
hr
Percuta-
neously by land-
mark technique
at the end of pro-
cedure
Used at the end
of operation
10 ml 0.25%
bupivacaine bo-
lus followed by
infusion at 5 ml/
hr
Messina 2009 Percuta-
neously by land-
mark technique
before induction
of GA
Used at the end
of operation only
0.
125% levobupi-
vacaine with fen-
tanyl 2 µg/ml
at 0.08 ml/kg/hr
infusion
Percuta-
neously by land-
mark technique
before induction
of GA
Used at the end
of operation
0.25% levobupi-
vacaine with fen-
tanyl 1.6 µg/ml
at 0.1 ml/kg/hr
infusion
Murkerjee 2010 Percuta-
neously by land-
mark technique
before induction
of GA
Used at the end
of operation only
15 ml of 0.25%
bupivacainewith
50µg of fentanyl
bolus
Percuta-
neously by land-
mark technique
before induction
of GA
Used at the end
of operation
7.5 ml of 0.25%
bupivacainewith
50µg of fentanyl
bolus
Perttunen 1995 Inserted by sur-
geon under di-
rect vision
Used at the end
of operation only
0.25%
bupivacaine bo-
lus according to
height, infusion
of 4 ml/hr, 6 ml/
hr, 8 ml/hr
Percuta-
neously by land-
mark technique
before induction
of GA
Used at the end
of operation
0.25%
bupivacaine bo-
lus according to
height, infusion
of 4 ml/hr, 6 ml/
hr, 8 ml/hr
Pintaric 2011 Percuta-
neously by land-
mark technique
before induction
of GA
0.5% levop-
ubivacaine with
30 µg/kg mor-
phine, dose de-
pends on height
0.
125% levobupi-
vacaine with 20
µg/ml morphine
infusion at 0.
1 ml/kg/hr with
PCEA
Percuta-
neously by land-
mark technique
before induction
of GA
0.25% levopubi-
vacaine with 30
µg/kg mor-
phine, dose de-
pends on height
0.
125% levobupi-
vacaine with 20
µg/ml morphine
infusion at 0.
1 ml/kg/hr with
PCEA
Richardson
1999
Inserted by sur-
geon under di-
rect vision
Pre-op In-
jections by land-
mark technique
before induction
of GA
20 ml of 0.5%
bupivacaine
20 ml bolus of 0.
5% bupivacaine,
followed by infu-
sion at 0.1 ml/
kg/hr
Percuta-
neously by land-
mark technique
before induction
of GA
10 - 15 ml bolus
of 0.25% bupi-
vacaine
10 ml bolus of 0.
25%
bupivacaine, fol-
lowed by infu-
sion at 0.1 ml/
kg/hr
GA: general anaesthesia
hr: hour
kg: kilogram
ml: millilitres
PCEA: patient-controlled epidural analgesia
PVB: paravertebral blockade
TEB: thoracic epidural blockade
µg: micrograms
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Table 2. VAS measurements by study
STUDY VAS range VAS reported Timing of VAS Time points VAS
reported
Supplementary
analgesia
CONCLUSION
Bimston 1999 0 - 10 Mean At rest 8, 16, 24, 32, 49,
48, 56, 64, 72, 80,
88, 96 hrs
Not reported TEB superior to
PVB for first 32
hrs
Casati 2006 0 - 10 Mean (SD) At rest
On coughing
Recovery, 12, 24,
48 hrs
Not reported PVBas effective as
TEB
DeCosmo2002 0 - 10 Mean (SD) At rest
On movement
1, 4, 8, 12, 24, 36,
48 hrs
Overall
mean consump-
tion of ketolorac
reported
PVBas effective as
TEB
Lower VAS scores
in TEB first 8 hrs
Grider 2012 0 - 10 Mean (SD) At rest
During
physiotherapy
Recovery, day 1
am, day 2 am/pm,
day 3 am/pm, day
4 am
Number of par-
ticipants in whom
tech-
nique failed and
PCA prescribed
PVB as effective
as TEB (plain LA)
however
TEB with opiate
was superior
Gulbahar 2010 0 - 10 Mean At rest Day 1, 2, 3 Daily number of
PCEA request
PVBas effective as
TEB
Ibrahim 2009 0 - 5 Mean At rest 4, 8, 12, 16, 20,
24 hrs
Rescue morphine
recorded but not
published
PVBas effective as
TEB
Kaiser 1998 0 - 4 Mean (SD) At rest Day 0, 1, 2, 3, 4,
5
Mean daily con-
sumption of nico-
morphine
PVBas effective as
TEB
PVB superior at
72 and 96 hrs
Kobayashi
2013
0 - 10 Mean (SD) At rest
On coughing
On exercise
2, 5, 16, 20, 24,
48 hrs
Frequency of ad-
ditional analgesic
(non-specified)
PVBas effective as
TEB
Matthews 1989 0 - 10 Mean (SD) At rest 4, 12, 24 hrs Not recorded PVBas effective as
TEB
Messina 2009 0 - 10 Mean (SD) At rest
On movement
Recovery, 6, 24,
48, 72 hrs
Median
cumulative mor-
phine daily (mg)
PVBas effective as
TEB
Murkerjee 2010 NA NA NA NA NA Single bolus PVB
supe-
rior, lasted statisti-
cally significantly
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Table 2. VAS measurements by study (Continued)
longer than TEB
PVB: 171.66 (77.
31) vs TEB: 105.
83 (33.28)
Perttunen 1995 0 - 5 Mean (Range) At rest
On coughing
1, 2, 4, 6, 20, 24,
30, 48 hrs
Mean cumulative
PCA morphine
consumption ev-
ery 3 hrs
PVBas effective as
TEB
Pintaric 2011 0 - 10 Mean (SD) At rest
After physiother-
apy
6, 24, 48 hrs Mean con-
sumption of pir-
itramide
PVBas effective as
TEB
Richardson
1999
0 - 10 Mean, median,
IQR
At rest
On coughing
4, 8, 12, 16, 20,
24, 28, 32, 36, 40,
44, 48 hrs
Mean cumulative
morphine
consumption
PVB superior to
TEB
am: ante meridiem
hr: hour
IQR: interquartile range
LA: local anaesthetic
mg: milligram
NA: not applicable
PCA: patient-controlled analgesia
PCEA: patient-controlled epidural analgesia
PVB: paravertebral blockade
TEB: thoracic epidural blockade
pm: post meridiem
SD: standard deviation
VAS: visual analogue scale;
Table 3. VAS measurements by time points
Visual Analogue Scales Studies Effect of intervention
2 - 6 hrs at rest De Cosmo 2002
Grider 2012
Kobayashi 2013
Matthews 1989
Messina 2009
Pintaric 2011
No difference
Standard mean difference 0.32, 95% CI -
0.30 to 0.94
P value = 0.31
95% PI -2.35 to 3.15
2 - 6 hrs during coughing/on movement De Cosmo 2002
Grider 2012
Pintaric 2011
No difference
Standard mean difference 0.41, 95% CI -
0.20 to 1.03
P value = 0.06
95% PI -10.66 to 11.64
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Table 3. VAS measurements by time points (Continued)
24 hrs at rest De Cosmo 2002
Grider 2012Grider 2012
Kobayashi 2013
Matthews 1989
Messina 2009
Pintaric 2011
No difference
Standard mean difference 0.16, 95% CI -
0.17 to 0.48
P value = 0.34
95% PI -0.25 to 0.69
24 hrs during coughing/on movement De Cosmo 2002
Grider 2012
Pintaric 2011
No difference
Standard mean difference -0.23, 95% CI -
0.58 to 0.12
P value = 0.20
95% PI -3.73 to 3.33
48 hrs at rest De Cosmo 2002
Grider 2012
Kobayashi 2013
Messina 2009
Pintaric 2011
No difference
Standard mean difference -0.12, 95% CI -
0.46 to 0.22
P value = 0.49
95% PI -1.26 to 1.14
48 hrs during coughing/on movement De Cosmo 2002
Grider 2012
Pintaric 2011
No difference
Standard mean difference 0.25, 95% CI -
0.16 to 0.66
P value = 0.22
95% PI -1.54 to 2.10
CI: confidence interval
95% PI: 95% prediction interval. Analysed using random-events model
VAS: visual analogue scale
Table 4. Duration of hospital stay
Study Number of days PVB group (median, range) Number of days TEB group (median, range)
Bimston 1999 5 6
Perttunen 1995 7.7 (6 - 16) 7.3 (5 - 11)
Richardson 1999 6.7 (4 - 11) 6.7 (3 - 16)
PVB: paravertebral blockade
TEB: thoracic epidural blockade
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A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor Analgesia, Epidural explode all trees
#2 MeSH descriptor Anesthesia, Epidural explode all trees
#3 MeSH descriptor Nerve Block explode all trees
#4 MeSH descriptor Length of Stay explode all trees
#5 MeSH descriptor Postoperative Nausea and Vomiting explode all trees
#6 MeSH descriptor Arrhythmias, Cardiac explode all trees
#7 MeSH descriptor Postoperative Complications explode all trees
#8 MeSH descriptor Cost-Benefit Analysis explode all trees
#9 MeSH descriptor Pain, Postoperative explode all trees
#10 epidural:ti,ab or (block near (paravertebral or extrapleural or subpleural or retropleural or intercostal))
#11 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10)
#12 MeSH descriptor Thoracotomy explode all trees
#13 Thoracotomy
#14 (#12 OR #13)
#15 (#11 AND #14)
Appendix 2. MEDLINE (via Ovid) search strategy
1. exp Analgesia, Epidural/ or exp Anesthesia, Epidural/ or epidural.mp. or expNerveBlock/ or (block adj5 (paravertebral or extrapleural
or subpleural or retropleural or intercostal)).mp. or “Length of Stay”/ or “PostoperativeNausea andVomiting”/ or Arrhythmias, Cardiac/
or Postoperative Complications/ or Cost-Benefit Analysis/ or Pain, Postoperative/
2. Thoracotomy.af. or exp Thoracotomy/
3. 1 and 2
4. ((randomised controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or ran-
domly.ab. or trial.ti.) not (animals not (humans and animals)).sh.
5. 3 and 4
Appendix 3. EMBASE (Ovid SP) search strategy
1. exp epidural anaesthesia/ or epidural.mp. or exp nerve block/ or (block adj3 (paravertebral or extrapleural or subpleural or retropleural
or intercostal)).mp. or length of stay/ or postoperative nausea/ or postoperative vomiting/ or heart arrhythmia/ or postoperative
complication/ or cost benefit analysis/ or postoperative pain/
2. Thoracotomy.af. or exp thoracotomy/
3. (placebo.sh. or controlled study.ab. or random*.ti,ab. or trial*.ti,ab. or ((singl* or doubl* or trebl* or tripl*) adj3 (blind* or
mask*)).ti,ab.) not (animals not (humans and animals)).sh.
4. 1 and 2 and 3
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Appendix 4. CINAHL (EBSCO host) search strategy
S1 ( (MH “Analgesia, Epidural”) OR (MH “Nerve Block”) OR (MH “Length of Stay”) OR (MH “Postoperative Pain”) OR (MH
“Postoperative Complications”) OR (MH “Arrhythmia, Ventricular”) OR (MH “Arrhythmia, Sinus”) OR (MH “Arrhythmia, Atrial”)
OR (MH “Cost Benefit Analysis”) ) OR AB epidural OR ( block and (paravertebral or extrapleural or subpleural or retropleural or
intercostal) )
S2 AB thoracotomy OR AB thoracotomy
S3 S1 and S2
Appendix 5. Data extraction form
Cochrane Anaesthesia Review Group
Study Selection, Quality Assessment and Data Extraction Form
First author Journal/Conference Proceedings etc Year
Study eligibility
RCT Relevant participants Relevant interventions Relevant outcomes
Yes / No / Unclear Yes / No / Unclear Yes / No / Unclear Yes / No* / Unclear
Do not proceed if any of the above answers are ‘No’. If study to be included in ‘Excluded studies’ section of the review, record below
the information to be inserted into ‘Table of excluded studies’
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Freehand space for comments on study design and treatment:
References to trial
Check other references identified in searches. If there are further references to this trial link the papers now & list below. All references
to a trial should be linked under one Study ID in RevMan.
Code each paper Author(s) Journal/Conference Proceedings etc Year
A
B
Participants and trial characteristics
Participant characteristics
Further details
Age (mean, median, range, etc)
Sex of participants (numbers / %, etc)
Disease status / type, etc (if applicable)
Other
Methodological quality
Allocation of intervention
State here method used to generate allocation and reasons for
grading
Grade (circle)
Low risk of bias
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(Continued)
High risk of bias
Unclear
Concealment of allocation
Process used to prevent foreknowledge of group assignment in a RCT, which should be seen as distinct from blinding
State here method used to conceal allocation and reasons for grad-
ing
Grade (circle)
Low risk of bias
High risk of bias
Unclear
Blinding
Person responsible for participants care Low risk of bias/High risk of bias/Unclear
Participant Low risk of bias/High risk of bias/Unclear
Outcome assessor Low risk of bias/High risk of bias/Unclear
Other (please specify) Low risk of bias/High risk of bias/Unclear
Intention-to-treat
An intention-to-treat analysis is one in which all the participants in a trial are analysed according to the intervention to which they
were allocated, whether they received it or not
All participants entering trial
15% or fewer excluded
More than 15% excluded
Not analysed as ‘intention-to-treat’
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(Continued)
Unclear
Were withdrawals described? Yes ? No ? not clear ?
Discuss if appropriate
Data extraction
Outcomes relevant to your review
• Denotes primary outcomes
Reported in paper (circle)
Significant arrhythmias* Yes / No
Pulmonary complications including ventilatory support* Yes / No
Unexpected critical care admissions* Yes / No
Further surgery* Yes / No
Inotropic support* Yes / No
30 day mortality* Yes / No
Analgesic efficacy (VAS, morphine, additional analgesia) Yes / No
Nausea & vomiting Yes / No
Failure of technique Yes / No
Urinary retention Yes / No
Duration of hospital stay Yes / No
Cost effectiveness Yes / No
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For Continuous data
Code of paper
Outcomes
Unit of mea-
surement
Intervention group Control group Details if outcome
only described in
text
n Mean (SD) n Mean (SD)
Significant ar-
rhythmias*
Pul-
monary com-
plications/
Ventilator
support*
Un-
expected ICU
admission*
Further
surgery*
Inotropic sup-
port*
30 daymortal-
ity*
Analgesic effi-
cacy
N&V
Failure of
technique
Urinary reten-
tion
Duration of
hospital stay
Cost effective-
ness
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For Dichotomous data
Code of paper Outcomes (rename) Intervention group (n)
n = number of participants, not
number of events
Control group (n)
n = number of participants, not
number of events
A Significant arrhythmias*
Pulmonary complications/ Venti-
lator support*
Unexpected ICU admission*
Further surgery*
Inotropic support*
30 day mortality*
Analgesic efficacy
N&V
Failure of technique
Urinary retention
Duration of hospital stay
Cost effectiveness
Other information which you feel is relevant to the results
Indicate if: any data were obtained from the primary author; if results were estimated from graphs etc; or calculated by you using a
formula (this should be stated and the formula given). In general if results not reported in paper(s) are obtained this should be made
clear here to be cited in review
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Freehand space for writing actions such as contact with study authors and changes
References to other trials
Did this report include any references to published reports of potentially eligible trials not already identified for this review?
First author Journal / Conference Year of publication
Did this report include any references to unpublished data from potentially eligible trials not already identified for this review? If yes,
give list contact name and details
Trial characteristics
Further details
Single centre / Multicentre
Country / Countries
How was participant eligibility defined?
How many people were randomized?
Number of participants in each intervention group
Number of participants who received intended treatment
Number of participants who were analysed
Drug treatment(s) used
Dose / frequency of administration
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(Continued)
Duration of treatment (State weeks / months, etc, if cross-over
trial give length of time in each arm)
Median (range) length of follow-up reported in this paper (state
weeks, months or years or if not stated)
Time-points when measurements were taken during the study
Time-points reported in the study
Time-points you are using in RevMan
Trial design (e.g. parallel / cross-over*)
Other
* If cross-over design, please refer to the Cochrane Editorial Office for further advice on how to analyse these data
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
1. There has been a change from the protocol authorship (Yeung 2011), Dr Matthew Wilson has replaced Professor Martin Leuwer
as one of the co-authors of the review.
2. The handsearching of the Journal of Cardiothoracic Surgery and Journal of Cardiothoracic and Vascular Anesthesia (from 1996 to
2013) yielded a much higher number of articles than previously expected. The handsearching has been added to Search methods for
identification of studies section.
3. We intended to include cluster-randomized controlled trials but found no suitable cluster-randomized controlled trials.
4. We planned to review trial protocol or registration to assess selective reporting but found no protocol or registration for included
studies.
5. We were not able to pool results from all included studies due to high heterogeneity found in terms of technique of TEB and
PVB insertion, the type of anaesthetic given through TEB and PVB, method and duration of use.
6. There were not enough data to allow for subgroup analyses.
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